Long-term effects of alcohol

Last updated

The long-term effects of alcohol have been extensively researched. The health effects of long-term alcohol consumption on health vary depending on the amount consumed. Even light drinking poses health risks, [1] but atypically small amounts of alcohol may have health benefits. [2] Alcoholism causes severe health consequences which outweigh any potential benefits. [3]

Contents

Long-term alcohol consumption is capable of damaging nearly every organ and system in the body. [4] Risks include malnutrition, cirrhosis, chronic pancreatitis, erectile dysfunction, hypertension, coronary heart disease, ischemic stroke, heart failure, atrial fibrillation, gastritis, stomach ulcers, alcoholic liver disease, [5] certain types of dementia, and several types of cancer, including oropharyngeal cancer, esophageal cancer, liver cancer, colorectal cancer, and female breast cancers. [6] In addition, damage to the central nervous system and peripheral nervous system (e.g., painful peripheral neuropathy) can occur from chronic heavy alcohol consumption. [7] [8] There is also an increased risk for accidental injuries, for example, those sustained in traffic accidents and falls. Excessive alcohol consumption can have a negative impact on aging. [9] The developing adolescent brain is particularly vulnerable to the toxic effects of alcohol. [10] In addition, the developing fetal brain is also vulnerable, and fetal alcohol spectrum disorders (FASDs) may result if pregnant mothers consume alcohol. Some nations have introduced alcohol packaging warning messages that inform consumers about alcohol and cancer, and about risk of fetal alcohol syndrome for women who drink while pregnant. [11]

Conversely, light intake of alcohol may have some beneficial effects. The association of alcohol intake with reduced cardiovascular risk has been noted since 1904 [12] and remains even after adjusting for known confounders. Light alcohol intake is also associated with reduced risk of type 2 diabetes, [13] gastritis, and cholelithiasis. [14] However, these are only observational studies and high-quality evidence for the beneficial effects of alcohol is nonexistent. [15] Alcohol does have psychosocial benefits such as stress reduction, mood elevation, increased sociability, and relaxation, [3] but it is unclear if these outweigh the confirmed increase in the risk of cancer. [15]

Overall effect

Disability-adjusted life year for alcohol use disorders per 100,000 inhabitants in 2004:
.mw-parser-output .div-col{margin-top:0.3em;column-width:30em}.mw-parser-output .div-col-small{font-size:90%}.mw-parser-output .div-col-rules{column-rule:1px solid #aaa}.mw-parser-output .div-col dl,.mw-parser-output .div-col ol,.mw-parser-output .div-col ul{margin-top:0}.mw-parser-output .div-col li,.mw-parser-output .div-col dd{page-break-inside:avoid;break-inside:avoid-column}
.mw-parser-output .legend{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .legend-color{display:inline-block;min-width:1.25em;height:1.25em;line-height:1.25;margin:1px 0;text-align:center;border:1px solid black;background-color:transparent;color:black}.mw-parser-output .legend-text{}
No data
Less than 50
50-150
150-250
250-350
350-450
450-550
550-650
650-750
750-850
850-950
950-1050
more than 1050 Alcohol use disorders world map - DALY - WHO2004.svg
Disability-adjusted life year for alcohol use disorders per 100,000 inhabitants in 2004:
  No data
  Less than 50
  50–150
  150–250
  250–350
  350–450
  450–550
  550–650
  650–750
  750–850
  850–950
  950–1050
  more than 1050

The level of ethanol consumption that minimizes the risk of disease, injury, and death is subject to some controversy. [16] Several studies have found a J-shaped relationship between alcohol consumption and health, [17] [18] [2] [19] meaning that risk is minimized at a certain (non-zero) consumption level, and drinking below or above this level increases risk, with the risk level of drinking a large amount of alcohol greater than the risk level of abstinence. Other studies have found a dose-response relationship, with lifetime abstention from alcohol being the optimal strategy and more consumption incurring more risk. [20] The studies use different data sets and statistical techniques so cannot be directly compared. Some older studies included former and occasional drinkers in the "abstainers" category, which obscures the benefits of lifetime abstention as former drinkers often are in poor health. [21] However, the J-curve was reconfirmed by studies that took the mentioned confounders into account. [22] [23] [24] [25] Nonetheless, some authors remain suspicious that the apparent health benefits of light alcohol use are in large part due to various selection biases and competing risks. [18] [26] Mendelian randomization studies have been inconsistent regarding the risk curve, with 3 studies finding linear dose-response risks overall and 2 studies finding a J-shape for lipid profiles. The variance in alcohol consumption that is explained by genetics is small, requiring large sample sizes and potentially violating assumptions of the analysis. [27]

As one reviewer noted, "Despite the wealth of observational data, it is not absolutely clear that alcohol reduces risk, because no randomized controlled trials have been performed." [28] The NIAAA announced a randomized controlled trial in 2017, but the NIH cancelled it in 2018 due to irregular interactions by the program staff with the alcohol industry. [29] [30] A trial in Spain is expected to complete in 2028. [31] Fekjær compares the present situation to those of hormone replacement therapy (HRT), vitamin E, and β-carotene. Similarly to alcohol, observational studies for each of these treatments showed significantly reduced risk of coronary heart disease. However, initial randomized trials of these treatments failed to replicate the effect. [15] For HRT, pooling multiple RCTs and stratifying the data by age and time since menopause showed the benefits were limited to treatment soon after menopause. [32] For vitamin E, trials have shown that the benefits are limited to certain populations such as those with diabetes and a specific genotype. [33] For β-carotene, the randomized trials have shown that β-carotene increases CVD risk when supplemented, with all beneficial effects due to other vitamins in foods providing β-carotene. [34]

In light of the conflicting evidence, many have cautioned against recommendations for the use of alcohol for health benefits. At a symposium in 1997, Peter Anderson labeled such alcohol promotion as "ridiculous and dangerous". [35] [36] It has been argued that the health benefits from alcohol have been exaggerated by the alcohol industry, with industry participation in the wording of messages and warnings. [37] [38] The debate is not purely scientific, with groups such as ISFAR critiquing anti-alcohol studies as distorting the evidence, [39] [40] scientists in turn accusing these groups of bias due to industry funding, [41] [42] and members of the groups responding that these are false and misleading assertions. [43] Studies with industry funding find less risk of stroke, [44] and industry-linked systematic reviews consistently find cardioprotective effects, compared to reviews with no associations being 54% positive. [45]

Considered as a treatment for cardiovascular disease, alcohol is addictive, has greater risk of adverse effects, and is less effective than other interventions such as heart medications, [35] exercise, or good nutrition. [46] The available evidence is in agreement that current drinking levels are too high. The World Health Organization has emphasized the need to revise alcohol control policies worldwide in order to reduce overall alcohol consumption. [1]

The World

Globally, assuming the J-shaped curve is correct, the age-standardised, both-sexes consumption that minimizes risk is about 5 grams of ethanol per day, and an average individual would cause themselves harm by drinking more than 17 grams per day. [2] However, the average intake among current drinkers in 2016 was approximately 40 grams of ethanol per day. [a] 1.03 billion males (35.1% of the male population aged ≥15 years, ~2/3 of male drinkers) and 312 million females (10.5% of the female population aged ≥15 years, ~1/3 of female drinkers) consumed harmful amounts of alcohol. [2] [b] The proportion of the population consuming harmful amounts of alcohol has stayed at approximately the same level over the past three decades. [2]

Estimates of the worldwide number of deaths per year caused by alcohol vary. The GBD 2016 study estimated 2.8 million, while the GBD 2020 study estimated 1.78 million. [47] The WHO estimates 3 million deaths per year from harmful use of alcohol, representing 5.3% of all deaths across the globe. [48] All of these numbers are net deaths, subtracting deaths prevented from deaths caused. Stockwell argues that alcohol may not prevent any deaths and guesses that as many as 6 million deaths may be caused by alcohol. [47] Besides this, the World Health Organization attributes 5.1% of the global burden of disease and injury to alcohol, as measured in disability-adjusted life years (DALYs). [48] The WHO does not list alcohol in its 2019 list of the top 20 leading causes of DALYs, but alcohol use disorder would rank around #39, combining AUD with alcohol-related cirrhosis and liver cancer would rank between malaria (#19) and refractive errors (#20), and all alcohol-attributed DALYs would rank between stroke (#3) and lower respiratory infections (#4). [49] Similarly the number of alcohol-attributed deaths would rank between chronic obstructive pulmonary disease (#3) and lower respiratory infections (#4). [50]

Research of Western cultures has consistently shown increased survival associated with light to moderate alcohol consumption. [21] [51] [52] Australasia and Europe are also the locations with the highest levels of harmful alcohol consumption. [2] Researchers have investigated cultures with different alcohol consumption norms and found conflicting results.[ citation needed ]

The risks of alcohol consumption are age-dependent. Risk is greatest among males aged 15–39 years, [2] due to binge drinking which may result in violence or traffic accidents. [21] It is less risky and potentially more beneficial for an older individual to consume a given amount of alcohol, compared to a similar younger individual, as they are less likely to develop cancer during their remaining lifespan, less likely to be involved in accidents, and more likely to benefit from alcohol's cardiovascular effects. Taking the lower bound of the confidence intervals, the GBD 2020 study suggests that people do not need to drink until age 25, and in many regions, the study did not find any significant benefit for drinking over abstinence even as late as ages 45 or 60. [2] Other studies have found similar patterns. [53]

India

A large study of 4465 subjects in India confirmed the possible harm of alcohol consumption on coronary risk in men. Compared to lifetime abstainers, alcohol users had higher blood sugar (2 mg/dl), blood pressure (2 mm Hg) levels, and the HDL-C levels (2 mg/dl) and significantly higher tobacco use (63% vs. 21%). Asian Indians who consume alcohol had a 60% higher risk of heart attack which was greater with local spirits (80%) than branded spirits (50%). [54] The harm was observed in alcohol users classified as occasional as well as regular light, moderate, and heavy consumers. [54]

Russia

A study by Zaridze et al. found that "excessive alcohol consumption in Russia, particularly by men, has in recent years caused more than half of all the deaths at ages 15–54 years." [55] However, there are some difficulties with this study. For instance, the same study also found a protective effect of heavy drinking on breast cancer mortality. Other studies have found that alcohol increases breast cancer risk. [56] The study used 43,802 deaths linked to alcohol or tobacco but only 5475 other deaths as controls. [55] Competing causes of death might have confounded the results through a lack of data on other risk factors. For example, the study may have attributed a death to alcohol-related causes, even when a woman was diagnosed with terminal breast cancer. [57]

South Asia

The landmark INTERHEART Study has revealed that alcohol consumption in South Asians was not protective against CAD in sharp contrast to other populations who benefit from it. [58]

United Kingdom

A governmental report from Britain has found that "There were 8,724 alcohol-related deaths in 2007, lower than 2006, but more than double the 4,144 recorded in 1991. The alcohol-related death rate was 13.3 per 100,000 population in 2007, compared with 6.9 per 100,000 population in 1991." [59] In Scotland, the NHS estimate that in 2003 one in every 20 deaths could be attributed to alcohol. [60] A 2009 report noted that the death rate from alcohol-related disease was 9,000, a number three times that of 25 years previously. [61]

A UK report came to the result that the effects of low-to-moderate alcohol consumption on mortality are age-dependent. Low-to-moderate alcohol use increases the risk of death for individuals aged 16–34 (due to increased risk of cancers, accidents, liver disease, and other factors), but decreases the risk of death for individuals ages 55+ (due to decreased risk of ischemic heart disease). [62]

A study in the United Kingdom found that alcohol causes about 4% of cancer cases in the UK (12,500 cases per year). [63]

United States

The Centers for Disease Control and Prevention (CDC) report, "From 2001–2005, there were approximately 79,000 deaths annually attributable to excessive alcohol use. In fact, excessive alcohol use is the 3rd leading lifestyle-related cause of death for people in the United States each year." [64] A 1993 study estimated US deaths through alcohol at 100,000. [65] Another CDC report from 2001 estimated that medium and high consumption of alcohol led to 75,754 deaths in the United States in 2001. Low consumption of alcohol had some beneficial effects, so a net 59,180 deaths were attributed to alcohol. [66] New research in 2024 reveals that alcohol-related deaths among Americans more than doubled from 1999 to 2020. [67] In 2020, alcohol was linked to nearly 50,000 deaths among adults aged 25 to 85, a sharp rise from just under 20,000 in 1999. [68] All age groups experienced increases, with the most significant rise occurring in individuals aged 25 to 34, where death rates nearly quadrupled during this period.

Cardiovascular system

Alcohol has been found to have anticoagulant properties. [69] Thrombosis is lower among moderate drinkers than abstainers. [70] A meta-analysis of randomized trials found that alcohol consumption in moderation decreases serum levels of fibrinogen, a protein that promotes clot formation, while it increases levels of tissue type plasminogen activator, an enzyme that helps dissolve clots. [71] These changes were estimated to reduce coronary heart disease risk by about 24%. Another meta-analysis in 2011 found favorable changes in HDL cholesterol, adiponectin, and fibrinogen associated with moderate alcohol consumption. [72] A systematic review based on 16,351 participants showed J-shaped curve for the overall relationship between cardiovascular mortality and alcohol intake. Maximal protective effect was shown with 5–10 g of alcohol consumption per day and the effect was significant up to 26 g/day alcohol consumption. [73] Serum levels of C-reactive protein (CRP), a putative marker of inflammation and predictor of CHD (coronary heart disease) risk, are lower in moderate drinkers than in those who abstain from alcohol, suggesting that alcohol consumption in moderation might have anti-inflammatory effects. [74] [75] [76] Data from one prospective study suggest that, among men with initially low alcohol consumption (</=1 drink per week), a subsequent moderate increase in alcohol consumption may lower their CVD risk. [77]

Peripheral arterial disease

A prospective study published in 1997 found "moderate alcohol consumption appears to decrease the risk of PAD in apparently healthy men." [78] In a large population-based study, moderate alcohol consumption was inversely associated with peripheral arterial disease in women but not in men. But when confounding by smoking was considered, the benefit extended to men. The study concluded "an inverse association between alcohol consumption and peripheral arterial disease was found in nonsmoking men and women." [79] [80]

Intermittent claudication

A study found that moderate consumption of alcohol had a protective effect against intermittent claudication. The lowest risk was seen in men who drank 1 to 2 drinks per day and in women who drank half to 1 drink per day. [81]

Heart attack and stroke

Drinking in moderation has been found to help those who have had a heart attack survive it. [82] [83] [84] However, excessive alcohol consumption leads to an increased risk of heart failure. [85] A review of the literature found that half a drink of alcohol offered the best level of protection. However, they noted that at present there have been no randomised trials to confirm the evidence which suggests a protective role of low doses of alcohol against heart attacks. [86] There is an increased risk of hypertriglyceridemia, cardiomyopathy, hypertension, and stroke if three or more standard drinks of alcohol are taken per day. [87] A systematic review reported that reducing alcohol intake lowers blood pressure in a dose-dependent manner in heavy drinkers. For people who drank two or fewer drinks per day, no difference was found. [88]

Cardiomyopathy

Large amounts of alcohol over the long term can lead to alcoholic cardiomyopathy. Alcoholic cardiomyopathy presents in a manner clinically identical to idiopathic dilated cardiomyopathy, involving hypertrophy of the musculature of the heart that can lead to congestive heart failure. [89]

Hematologic diseases

Alcoholics may have anemia from several causes; [90] they may also develop thrombocytopenia from direct toxic effect on megakaryocytes, or from hypersplenism. [91]

Atrial fibrillation

Alcohol consumption increases the risk of atrial fibrillation, a type of abnormal heart rhythm. This remains true even at moderate levels of consumption. [92]

Nervous system

Chronic heavy alcohol consumption impairs brain development, causes alcohol dementia, brain shrinkage, physical dependence, alcoholic polyneuropathy (also known as 'alcohol leg'), increases neuropsychiatric and cognitive disorders and causes distortion of the brain chemistry. At present, due to poor study design and methodology, the literature is inconclusive on whether moderate alcohol consumption increases the risk of dementia or decreases it. [93] Evidence for a protective effect of low to moderate alcohol consumption on age-related cognitive decline and dementia has been suggested by some research; however, other research has not found a protective effect of low to moderate alcohol consumption. [94] Some evidence suggests that low to moderate alcohol consumption may speed up brain volume loss. [95] Chronic consumption of alcohol may result in increased plasma levels of the toxic amino acid homocysteine; [96] [97] which may explain alcohol withdrawal seizures, [98] alcohol-induced brain atrophy [99] and alcohol-related cognitive disturbances. [100] Alcohol's impact on the nervous system can also include disruptions of memory and learning (see Effects of alcohol on memory ), such as resulting in a blackout phenomenon.

Strokes

Epidemiological studies of middle-aged populations generally find the relationship between alcohol intake and the risk of stroke to be either U- or J-shaped. [101] [102] [103] [104] There may be very different effects of alcohol based on the type of stroke studied. The predominant form of stroke in Western cultures is ischemic, whereas non-western cultures have more hemorrhagic stroke. In contrast to the beneficial effect of alcohol on ischemic stroke, consumption of more than two drinks per day increases the risk of hemorrhagic stroke. The National Stroke Association estimates this higher amount of alcohol increases stroke risk by 50%. [105] "For stroke, the observed relationship between alcohol consumption and risk in a given population depends on the proportion of strokes that are hemorrhagic. Light-to-moderate alcohol intake is associated with a lower risk of ischemic stroke which is likely to be, in part, causal. Hemorrhagic stroke, on the other hand, displays a log-linear relationship with alcohol intake." [106]

Brain

Alcohol misuse is associated with widespread and significant brain lesions. Alcohol related brain damage is not only due to the direct toxic effects of alcohol; alcohol withdrawal, nutritional deficiency, electrolyte disturbances, and liver damage are also believed to contribute to alcohol-related brain damage. [107]

Cognition and dementia

Excessive alcohol intake is associated with impaired prospective memory. This impaired cognitive ability leads to increased failure to carry out an intended task at a later date, for example, forgetting to lock the door or to post a letter on time. The higher the volume of alcohol consumed and the longer consumed, the more severe the impairments. [108] One of the organs most sensitive to the toxic effects of chronic alcohol consumption is the brain. In the United States approximately 20% of admissions to mental health facilities are related to alcohol-related cognitive impairment, most notably alcohol-related dementia. Chronic excessive alcohol intake is also associated with serious cognitive decline and a range of neuropsychiatric complications. The elderly are the most sensitive to the toxic effects of alcohol on the brain. [109] There is some inconclusive evidence that small amounts of alcohol taken in earlier adult life is protective in later life against cognitive decline and dementia. [110] However, a study concluded, "Our findings suggest that, despite previous suggestions, moderate alcohol consumption does not protect older people from cognitive decline." [111]

Wernicke–Korsakoff syndrome is a manifestation of thiamine deficiency, usually as a secondary effect of alcohol misuse. [112] The syndrome is a combined manifestation of two eponymous disorders, Korsakoff's Psychosis and Wernicke's encephalopathy. Wernicke's encephalopathy is the acute presentation of the syndrome and is characterised by a confusional state while Korsakoff's psychosis main symptoms are amnesia and executive dysfunction. [113] "Banana bags", intravenous fluid containers containing vitamins and minerals (bright yellow due to the vitamins), can be used to mitigate these outcomes. [114] [115]

Essential tremor

Essential tremors—or, in the case of essential tremors on a background of family history of essential tremors, familial tremors—can be temporarily relieved in up to two-thirds of patients by drinking small amounts of alcohol. [116]

Ethanol is known to activate aminobutyric acid type A (GABAA) and inhibit N-methyl-D-aspartate (NMDA) glutamate receptors, which are both implicated in essential tremor pathology [117] and could underlie the ameliorative effects. [118] [119] Additionally, the effects of ethanol have been studied in different animal essential tremor models. (For more details on this topic, see Essential tremor).

Sleep

Chronic use of alcohol used to induce sleep can lead to insomnia: frequent moving between sleep stages occurs, with awakenings due to headaches and diaphoresis. Stopping chronic alcohol misuse can also lead to profound disturbances of sleep with vivid dreams. Chronic alcohol misuse is associated with NREM stage 3 and 4 sleep as well as suppression of REM sleep and REM sleep fragmentation. During withdrawal REM sleep is typically exaggerated as part of a rebound effect. [120]

Mental health effects

High rates of major depressive disorder occur in heavy drinkers. Whether it is more true that major depressive disorder causes self-medicating alcohol use, or the increased incidence of the disorder in people with an alcohol use disorder is caused by the drinking, is not known though some evidence suggests drinking causes the disorder. [121] Alcohol misuse is associated with a number of mental health disorders and alcoholics have a very high suicide rate. [122] A study of people hospitalized for suicide attempts found that those who were alcoholics were 75 times more likely to go on to successfully commit suicide than non-alcoholic suicide attempts. [123] In the general alcoholic population the increased risk of suicide compared to the general public is 5-20 times greater. About 15 percent of alcoholics commit suicide, the most common methods being overdosing and cutting/scratching. There are high rates of suicide attempts, self-harm, suicidal ideation, and self-harm ideation in people with substance dependence who have been hospitalized. [124] Use of other illicit drugs is also associated with an increased risk of suicide. About 33 percent of suicides in the under 35s are correlated with alcohol or other substance misuse. [125]

Social skills are significantly impaired in people that have alcoholism due to the neurotoxic effects of alcohol on the brain, especially the prefrontal cortex area of the brain. The social skills that are impaired by alcohol use disorder include impairments in perceiving facial emotions, prosody perception problems and theory of mind deficits; the ability to understand humor is also impaired in people with an alcohol use disorder. [126]

Studies have shown that alcohol dependence relates directly to cravings and irritability. [127] Another study has shown that alcohol use is a significant predisposing factor towards antisocial behavior in children. [128] Depression, anxiety and panic disorder are disorders commonly reported by alcohol dependent people. Alcoholism is associated with dampened activation in brain networks responsible for emotional processing (e.g. the amygdala and hippocampus). [129] Evidence that the mental health disorders are often induced by alcohol misuse via distortion of brain neurochemistry is indicated by the improvement or disappearance of symptoms that occurs after prolonged abstinence, although problems may worsen in early withdrawal and recovery periods. [130] [131] [132] Psychosis is secondary to several alcohol-related conditions including acute intoxication and withdrawal after significant exposure. [133] Chronic alcohol misuse can cause psychotic type symptoms to develop, more so than with other illicit substances. Alcohol misuse has been shown to cause an 800% increased risk of psychotic disorders in men and a 300% increased risk of psychotic disorders in women which are not related to pre-existing psychiatric disorders. This is significantly higher than the increased risk of psychotic disorders seen from cannabis use making alcohol misuse a very significant cause of psychotic disorders. [134] Approximately 3 percent of people who are alcohol dependent experience psychosis during acute intoxication or withdrawal. Alcohol-related psychosis may manifest itself through a kindling mechanism. The mechanism of alcohol-related psychosis is due to distortions to neuronal membranes, gene expression, as well as thiamin deficiency. It is possible in some cases that excessive alcohol use, via a kindling mechanism, can cause the development of a chronic substance-induced psychotic disorder, i.e. schizophrenia. The effects of an alcohol-related psychosis include an increased risk of depression and suicide as well as psychosocial impairments. [133] However, moderate wine drinking has been shown to lower the risk for depression. [135]

While alcohol initially helps social phobia or panic symptoms, with longer term alcohol misuse can often worsen social phobia symptoms and can cause panic disorder to develop or worsen, during alcohol intoxication and especially during the alcohol withdrawal syndrome. This effect is not unique to alcohol but can also occur with long-term use of drugs which have a similar mechanism of action to alcohol such as the benzodiazepines, which are sometimes prescribed as tranquilizers to people with alcohol problems. [136] Approximately half of patients attending mental health services for conditions including anxiety disorders such as panic disorder or social phobia have alcohol or benzodiazepine dependence. It was noted that every individual has an individual sensitivity level to alcohol or sedative hypnotic drugs and what one person can tolerate without ill health another will have very ill health and that even moderate drinking can cause rebound anxiety syndromes and sleep disorders. A person who is experiencing the toxic effects of alcohol will not benefit from other therapies or medications as they do not address the root cause of the symptoms. [137]

Addiction to alcohol, as with any addictive substance tested so far, has been correlated with an enduring reduction in the expression of GLT1 (EAAT2) in the nucleus accumbens and is implicated in the drug-seeking behavior expressed nearly universally across all documented addiction syndromes. This long-term dysregulation of glutamate transmission is associated with an increase in vulnerability to both relapse-events after re-exposure to drug-use triggers as well as an overall increase in the likelihood of developing addiction to other reinforcing drugs. Drugs which help to re-stabilize the glutamate system such as N-acetylcysteine have been proposed for the treatment of addiction to cocaine, nicotine, and alcohol. [138]

The effect on depression and returning to drinking among individuals with alcohol dependence has always been controversial. Studies show that after doing a study on men and women hospitalized for alcohol dependence the likelihood of returning to drinking with depression is extremely high. A diagnosis of major depression at entry into an inpatient treatment for alcohol dependence showed shorter times to first drink and also relapse in both women and men. [139]

Digestive system and weight gain

The impact of alcohol on weight-gain is contentious: some studies find no effect, [140] others find decreased [141] or increased effect on weight gain.

Alcohol use increases the risk of chronic gastritis (stomach inflammation); [3] [142] it is one cause of cirrhosis, hepatitis, and pancreatitis in both its chronic and acute forms.

Metabolic syndrome

A national survey (NHANES) conducted in the U.S. concluded, "Mild to moderate alcohol consumption is associated with a lower prevalence of the metabolic syndrome, with a favorable influence on lipids, waist circumference, and fasting insulin. This association was strongest among whites and among beer and wine drinkers." [143] Similarly, a national survey conducted in Korea reported a J-curve association between alcohol intake and metabolic syndrome: "The results of the present study suggest that the metabolic syndrome is negatively associated with light alcohol consumption (1–15 g alcohol/d) in Korean adults," but risk increased at higher alcohol consumption. [144]

Gallbladder effects

Research has found that drinking reduces the risk of developing gallstones. Compared with alcohol abstainers, the relative risk of gallstone disease, controlling for age, sex, education, smoking, and body mass index, is 0.83 for occasional and regular moderate drinkers (< 25 ml of ethanol per day), 0.67 for intermediate drinkers (25-50 ml per day), and 0.58 for heavy drinkers. This inverse association was consistent across strata of age, sex, and body mass index." [145] Frequency of drinking also appears to be a factor. "An increase in frequency of alcohol consumption also was related to decreased risk. Combining the reports of quantity and frequency of alcohol intake, a consumption pattern that reflected frequent intake (5–7 days/week) of any given amount of alcohol was associated with a decreased risk, as compared with nondrinkers. In contrast, infrequent alcohol intake (1–2 days/week) showed no significant association with risk." [146]

A large self-reported study published in 1998 found no correlation between gallbladder disease and multiple factors including smoking, alcohol consumption, hypertension, and coffee consumption. [147] A retrospective study from 1997 found vitamin C (ascorbic acid) supplement use in drinkers was associated with a lower prevalence of gallbladder disease, but this association was not seen in non-drinkers. [148]

Liver disease

Alcoholic liver disease is a major public health problem. For example, in the United States up to two million people have alcohol-related liver disorders. [149] Chronic heavy alcohol consumption can cause fatty liver, cirrhosis, and alcoholic hepatitis. Treatment options are limited and consist of most importantly discontinuing alcohol consumption. In cases of severe liver disease, the only treatment option may be a liver transplant from alcohol abstinent donors. Research is being conducted into the effectiveness of anti-TNFs. Certain complementary medications, e.g., milk thistle and silymarin, appear to offer some benefit. [149] [150] Alcohol is a leading cause of liver cancer in the Western world, accounting for 32-45% of hepatic cancers. Up to half a million people in the United States develop alcohol-related liver cancer. [151] [152]

Pancreatitis

Alcohol misuse is a leading cause of both acute pancreatitis and chronic pancreatitis. [153] [154] Alcoholic pancreatitis can result in severe abdominal pain and may progress to pancreatic cancer. [155] Chronic pancreatitis often results in intestinal malabsorption, and can result in diabetes. [156]

Body composition

Alcohol affects the nutritional state of chronic drinkers. It can decrease food consumption and lead to malabsorption. It can also create imbalances in skeletal muscle mass and cause muscle wasting. Chronic consumption of alcohol can also increase the breakdown of important proteins in the body which can affect gene expression. [157]

Oral and dental implications

Oral cancer

The consumption of alcohol alone is not associated with an increased risk of oral squamous cell carcinoma (OSCC); however, the synergistic consumption of alcohol and tobacco is positively associated with the occurrence of (OSCC), and significantly increases an individual's risk. Studies confirm that alcohol dissolves the lipid component of epithelium and increases the permeability, amplifying the toxicity of carcinogenic components of tobacco. Limiting the overall consumption of the two has shown to reduce the risk of OSCC by three-fourth. The knowledge provided is useful for better understanding the differences in the effect of the combined consumption of alcohol and tobacco, in the development of OSCC. [158]

Alcohol consumption has frequently been associated with an increased risk of oral cancer in current literature. Studies have found that people that consume alcohol were two times more likely to develop oral cancer in comparison to people who did not. The mechanisms in which alcohol acts as a carcinogen within the oral cavity are currently not fully understood. It is thought to be a multifactorial disease which then gives rise to a cancerous lesion. Many theories have become apparent in research, including alcohol being responsible for high estrogen and androgen levels, specifically in women, which may facilitate the alcohol-related immunodeficiency and/or immunosuppression that causes carcinogenesis. Therefore, immediate cessation of the habit of alcohol consumption can aid in decreasing the risk of oral cancer. [159]

Alcohol-based mouthwashes used to be very common and can still be purchased for use today. Correlation in the presence of alcohol in mouthwashes with development of oral and pharyngeal cancer is unknown due to lack of evidence. However, it has been suggested that acetaldehyde, the first metabolite of ethanol, plays a role in the carcinogenesis of alcohol in oral cancer. Acetaldehyde, has been found to increase when in the salivary medium after an alcoholic beverage has been consumed and could possibly occur with alcohol-based mouthwashes as well, posing as a possible risk factor for oral cancer. However, more research must be conducted regarding these theories. [160]

Periodontitis

Periodontal disease Periodontal Disease.png
Periodontal disease

Alcohol consumption is associated with a higher risk of periodontitis, an inflammatory disease of the gums around the teeth. There was also found to be a dose-response relationship in which the risk of periodontitis increased by 0.4% for each additional gram of daily alcohol consumption. Mechanisms explaining the relationship between the two are still unclear; however, several explanations have been suggested. One explanation is the weakening of neutrophil activity by alcohol consumption which potentially leads to bacterial overgrowth and increases bacterial penetration subsequently leading to periodontal inflammation and periodontal disease. Characteristics of the disease include shrinkage of gingival height and increased mobility of teeth which may exfoliate if the disease continues to progress. A patient's consumption of alcohol needs to be monitored to estimate the risk of periodontitis, but further well-designed cohort studies are needed to reaffirm theses results. [161]

Other systems

Respiratory system

Chronic alcohol ingestion can impair multiple critical cellular functions in the lungs. [162] These cellular impairments can lead to increased susceptibility to serious complications from lung disease. Recent research cites alcoholic lung disease as comparable to liver disease in alcohol-related mortality. [163] Alcoholics have a higher risk of developing acute respiratory distress syndrome (ARDS) and experience higher rates of mortality from ARDS when compared to non-alcoholics. [164] In contrast to these findings, a large prospective study has shown a protective effect of moderate alcohol consumption on respiratory mortality. [165]

Kidney stones

Research indicates that drinking beer or wine is associated with a lower risk of developing kidney stones. [166] [167] [168] [169]

Sexual function in men

Low to moderate alcohol consumption is shown to have protective effect for men's erectile function. Several reviews and meta-analyses of existing literature show that low to moderate alcohol consumption significantly decrease erectile dysfunction risk. [170] [171] [172] [173]

Men's sexual behaviors can be affected dramatically by high alcohol consumption. Both chronic and acute alcohol consumption have been shown in most studies [174] [175] [176] (but not all [177] ) to inhibit testosterone production in the testes. This is believed to be caused by the metabolism of alcohol reducing the NAD+/NADH ratio both in the liver and the testes; since the synthesis of testosterone requires NAD+, this tends to reduce testosterone production. [178] [179]

Long term excessive intake of alcohol can lead to damage to the central nervous system and the peripheral nervous system resulting in loss of sexual desire and impotence in men. [180] This is caused by reduction of testosterone from ethanol-induced testicular atrophy, resulting in increased feminisation of males and is a clinical feature of alcohol abusing males who have cirrhosis of the liver. [181]

Hormonal imbalance

Excessive alcohol intake can result in hyperoestrogenisation. [182] It has been speculated that alcoholic beverages may contain estrogen-like compounds. In men, high levels of estrogen can lead to testicular failure and the development of feminine traits including development of male breasts, called gynecomastia. [183] [184] In women, increased levels of estrogen due to excessive alcohol intake have been related to an increased risk of breast cancer. [184] [185]

Diabetes mellitus

A meta-analysis determined the dose-response relationships by sex and end point using lifetime abstainers as the reference group. A U-shaped relationship was found for both sexes. Compared with lifetime abstainers, the relative risk (RR) for type 2 diabetes among men was most protective when consuming 22 g/day alcohol and became deleterious at just over 60 g/day alcohol. Among women, consumption of 24 g/day alcohol was most protective, and became deleterious at about 50 g/day alcohol.[ citation needed ] A systematic review on intervention studies in women also supported this finding. It reported that alcohol consumption in moderation improved insulin sensitivity among women. [13]

The way in which alcohol is consumed (i.e., with meals or binge drinking) affects various health outcomes. It may be the case that the risk of diabetes associated with heavy alcohol consumption is due to consumption mainly on the weekend as opposed to the same amount spread over a week. [186] In the United Kingdom "advice on weekly consumption is avoided".[ citation needed ] A twenty-year twin study from Finland reported that moderate alcohol consumption may reduce the risk of type 2 diabetes in men and women. However, binge drinking and high alcohol consumption was found to increase the risk of type 2 diabetes in women. [187]

Rheumatoid arthritis

Regular consumption of alcohol is associated with an increased risk of gouty arthritis [188] [189] and a decreased risk of rheumatoid arthritis. [190] [191] [192] [193] [194] Two recent studies report that the more alcohol consumed, the lower the risk of developing rheumatoid arthritis. Among those who drank regularly, the one-quarter who drank the most were up to 50% less likely to develop the disease compared to the half who drank the least. [195]

The researchers noted that moderate alcohol consumption also reduces the risk of other inflammatory processes such as cardiovascular disease. Some of the biological mechanisms by which ethanol reduces the risk of destructive arthritis and prevents the loss of bone mineral density (BMD), which is part of the disease process. [196]

A study concluded, "Alcohol either protects from RA or, subjects with RA curtail their drinking after the manifestation of RA". [197] Another study found, "Postmenopausal women who averaged more than 14 alcoholic drinks per week had a reduced risk of rheumatoid arthritis..." [198]

Osteoporosis

Moderate alcohol consumption is associated with higher bone mineral density in postmenopausal women. "...Alcohol consumption significantly decreased the likelihood [of osteoporosis]." [199] "Moderate alcohol intake was associated with higher BMD in postmenopausal elderly women." [200] "Social drinking is associated with higher bone mineral density in men and women [over 45]." [201] However, heavy alcohol use is associated with bone loss. [202] [203]

Skin

Chronic excessive alcohol use is associated with a wide range of skin disorders including urticaria, porphyria cutanea tarda, flushing, cutaneous stigmata of cirrhosis, psoriasis, pruritus, seborrheic dermatitis, and rosacea. [204]

A 2010 study concluded, "Nonlight beer intake is associated with an increased risk of developing psoriasis among women. Other alcoholic beverages did not increase the risk of psoriasis in this study." [205]

Immune system

Bacterial infection

Excessive alcohol consumption seen in people with an alcohol use disorder is a known risk factor for developing pneumonia.[ citation needed ]

Common cold

A study on the common cold found that "Greater numbers of alcoholic drinks (up to three or four per day) were associated with decreased risk for developing colds because drinking was associated with decreased illness following infection. However, the benefits of drinking occurred only among nonsmokers. ... Although alcohol consumption did not influence risk of clinical illness for smokers, moderate alcohol consumption was associated with decreased risk for nonsmokers." [206]

Another study concluded, "Findings suggest that wine intake, especially red wine, may have a protective effect against common cold. Beer, spirits, and total alcohol intakes do not seem to affect the incidence of common cold." [207]

Cancer

In 1988, the International Agency for Research on Cancer (Centre International de Recherche sur le Cancer) of the World Health Organization classified alcohol as a Group 1 carcinogen, stating "There is sufficient evidence for the carcinogenicity of alcoholic beverages in humans.... Alcoholic beverages are carcinogenic to humans (Group 1)." [208] The U.S. Department of Health & Human Services' National Toxicology Program in 2000 listed alcohol as a known carcinogen . [209]

It was estimated in 2006 that "3.6% of all cancer cases worldwide are related to alcohol drinking, resulting in 3.5% of all cancer deaths." [210] A European study from 2011 found that one in 10 of all cancers in men and one in 33 in women were caused by past or current alcohol intake. [211] [212] The World Cancer Research Fund panel report Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective finds the evidence "convincing" that alcoholic drinks increase the risk of the following cancers: mouth, pharynx and larynx, oesophagus, colorectum (men), breast (pre- and postmenopause). [213]

Even light and moderate alcohol consumption increases cancer risk in individuals, especially with respect to squamous cell carcinoma of the esophagus, oropharyngeal cancer, and breast cancer. [6] [214]

Acetaldehyde, a metabolic product of alcohol, is suspected to promote cancer. [215] Typically the liver eliminates 99% of acetaldehyde produced. However, liver disease and certain genetic enzyme deficiencies result in high acetaldehyde levels. Heavy drinkers who are exposed to high acetaldehyde levels due to a genetic defect in alcohol dehydrogenase have been found to be at greater risk of developing cancers of the upper gastrointestinal tract and liver. [216] A review in 2007 found "convincing evidence that acetaldehyde... is responsible for the carcinogenic effect of ethanol... owing to its multiple mutagenic effects on DNA." [217] Acetaldehyde can react with DNA to create DNA adducts including the Cr-PdG adduct. This Cr-PdG adduct "is likely to play a central role in the mechanism of alcoholic beverage related carcinogenesis." [218]

Alcohol's effect on the fetus

Fetal alcohol syndrome or FAS is a birth defect that occurs in the offspring of women who drink alcohol during pregnancy. More risks than benefits according to a survey of current knowledge. [219] Alcohol crosses the placental barrier and can stunt fetal growth or weight, create distinctive facial stigmata, damaged neurons and brain structures, and cause other physical, mental, or behavioural problems. [220] Fetal alcohol exposure is the leading known cause of intellectual disability in the Western world. [221] Alcohol consumption during pregnancy is associated with brain insulin and insulin-like growth factor resistance. [202]

Effects of alcoholism on family and children

Children raised in alcoholic families have the potential to suffer emotional distress as they move into their own committed relationships. These children are at a higher risk for divorce and separation, unstable marital conditions and fractured families. [222] Feelings of depression and antisocial behaviors experienced in early childhood frequently contribute to marital conflict and domestic violence. Women are more likely than men to be victims of alcohol-related domestic violence. [223] [224] [225] [226]

Children of alcoholics often incorporate behaviors learned as children into their marital relationships. These behaviors lead to poor parenting practices. For example, adult children of alcoholics may simultaneously express love and rejection toward a child or spouse. This is known as insecure attachment. [222] [225] [226] Insecure attachment contributes to trust and bonding issues with intimate partners and offspring. In addition, prior parental emotional unavailability contributes to poor conflict resolution skills in adult relationships. [222] Evidence shows a correlation between alcoholic fathers who display harsh and ineffective parenting practices with adolescent and adult alcohol dependence. [225] [226]

Children of alcoholics are often unable to trust other adults due to fear of abandonment. [222] Further, because children learn their bonding behaviors from watching their parents' interactions, daughters of alcoholic fathers may be unable to interact appropriately with men when they reach adulthood. [222] Poor behavior modeling by alcoholic parents contributes to inadequate understanding of how to engage in opposite gender interactions. [222]

Sons of alcoholics are at risk for poor self-regulation that is often displayed in the preschool years. This leads to blaming others for behavioral problems and difficulties with impulse control. Poor decision-making correlates to early alcohol use, especially in sons of alcoholics. [223] [224] [226] Sons often demonstrate thrill-seeking behavior, harm avoidance, and exhibit a low level of frustration tolerance. [224] [225] [226]

Economic impact from long-term consumption of alcohol

There is currently no consistent approach to measuring the economic impact of alcohol consumption. [227] The economic burden such as direct, indirect, and intangible cost of diseases can be estimated through cost-of-illness studies. [228] Direct costs are estimated through prevalence and incidence studies, while indirect costs are estimated through the human capital method, the demographic method, and the friction cost method. [227] However, it is difficult to accurately measure the economic impact due to differences in methodologies, cost items related to alcohol consumption, and measurement techniques.

Alcohol dependence has a far reaching impact on health outcomes. A study conducted in Germany in 2016 found the economic burden for those dependent on alcohol was 50% higher than those who were not. [229] In the study, over half of the economic cost was due to lost productivity, and only 6% was due to alcohol treatment programs. The economic cost was mostly borne by individuals between 30 and 49 years old. In another study conducted with data from eight European countries, [230] 77% of alcohol dependent patients had psychiatric and somatic co-morbidity, which in turn increased systematic healthcare and economic cost. Alcohol consumption can also affect the immune system and produce complications in people with HIV, pneumonia, and tuberculosis. [231]

Indirect costs due to alcohol dependence are significant. The biggest indirect cost comes from lost productivity, followed by premature mortality. [232] Men with alcohol dependence in the U.S. have lower labor force participation by 2.5%, lower earnings by 5.0%, and higher absenteeism by 0.5–1.2 days. Female binge drinkers have higher absenteeism by 0.4–0.9 days. Premature mortality is another large contributor to indirect costs of alcohol dependence. [233] In 2004, 3.8% of global deaths were attributable to alcohol (6.3% for men and 1.1% for women). Those under 60 years old have much higher prevalence in global deaths attributable to alcohol at 5.3%.

In general, indirect costs such as premature mortality due to alcohol dependence, loss of productivity due to absenteeism and presenteeism, and cost of property damage and enforcement, far exceed the direct health care and law enforcement costs. [234] Aggregating the economic cost from all sources, the impact can range from 0.45 to 5.44% of a country's gross domestic product (GDP). [235] The wide range is due to inconsistency in measurement of economic burden, as researchers in some studies attributed possible positive effects from long term alcohol consumption. [236] [237]

See also

Notes

  1. Calculated as (1.5*1.7/0.39+0.9*0.87/0.25)/(1.5+0.9), with figures from GBD 2016 Alcohol Collaboration (2018). See also WHO figures by country
  2. The fraction of current drinkers is estimated using WorldBank 2016 population numbers and combining the GBD 2016 and GBD 2020 analyses based on the statement that "Since 1990, the global proportion of drinkers consuming alcohol in excess of the NDE has not changed significantly." For example, GBD 2016 states there were 1.5 billion male current drinkers in 2016, WorldBank states there were 3,770,341,364 males and 1,018,695,045 males under 15, and we can assume based on GBD 2020 that 35.1% of males 15+ were drinking harmful amounts, so we calculate .351*(3770341364-1018695045)/1.5e9≈2/3

Related Research Articles

<span class="mw-page-title-main">Alcoholism</span> Problematic excessive alcohol consumption

Alcoholism is the continued drinking of alcohol despite it causing problems. Some definitions require evidence of dependence and withdrawal. Problematic use of alcohol has been mentioned in the earliest historical records. The World Health Organization (WHO) estimated there were 283 million people with alcohol use disorders worldwide as of 2016. The term alcoholism was first coined in 1852, but alcoholism and alcoholic are sometimes considered stigmatizing and to discourage seeking treatment, so diagnostic terms such as alcohol use disorder or alcohol dependence are often used instead in a clinical context.

<span class="mw-page-title-main">Alcohol abuse</span> Substance abuse of alcoholic beverages

Alcohol abuse encompasses a spectrum of alcohol-related substance abuse, ranging from the consumption of more than 2 drinks per day on average for men, or more than 1 drink per day on average for women, to binge drinking or alcohol use disorder.

<span class="mw-page-title-main">Alcoholic liver disease</span> Medical condition

Alcoholic liver disease (ALD), also called alcohol-related liver disease (ARLD), is a term that encompasses the liver manifestations of alcohol overconsumption, including fatty liver, alcoholic hepatitis, and chronic hepatitis with liver fibrosis or cirrhosis.

<span class="mw-page-title-main">French paradox</span> Observation that heart disease in French people is much less than is expected

The French paradox is an apparently paradoxical epidemiological observation that French people have a relatively low incidence of coronary heart disease (CHD), while having a diet relatively rich in saturated fats, in apparent contradiction to the widely held belief that the high consumption of such fats is a risk factor for CHD. The paradox is that if the thesis linking saturated fats to CHD is valid, the French ought to have a higher rate of CHD than comparable countries where the per capita consumption of such fats is lower.

<span class="mw-page-title-main">Cardiovascular disease</span> Class of diseases that involve the heart or blood vessels

Cardiovascular disease (CVD) is any disease involving the heart or blood vessels. CVDs constitute a class of diseases that includes: coronary artery diseases, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.

<span class="mw-page-title-main">Alcoholic hepatitis</span> Medical condition

Alcoholic hepatitis is hepatitis due to excessive intake of alcohol. Patients typically have a history of at least 10 years of heavy alcohol intake, typically 8–10 drinks per day. It is usually found in association with fatty liver, an early stage of alcoholic liver disease, and may contribute to the progression of fibrosis, leading to cirrhosis. Symptoms may present acutely after a large amount of alcoholic intake in a short time period, or after years of excess alcohol intake. Signs and symptoms of alcoholic hepatitis include jaundice, ascites, fatigue and hepatic encephalopathy. Mild cases are self-limiting, but severe cases have a high risk of death. Severity in alcoholic hepatitis is determined several clinical prediction models such as the Maddrey's Discriminant Function and the MELD score.

<span class="mw-page-title-main">Alcohol and cardiovascular disease</span> Effects of alcohol consumption on cardiovascular health

In a 2018 study on 599,912 drinkers, a roughly linear association was found with alcohol consumption and a higher risk of stroke, coronary artery disease excluding myocardial infarction, heart failure, fatal hypertensive disease, and fatal aortic aneurysm, even for moderate drinkers. Alcohol abuse may also cause occupational cardiovascular disease. The American Heart Association states that people who are currently non-drinkers should not start drinking alcohol.

<span class="mw-page-title-main">Alcohol and cancer</span> Relationship between cancer and the consumption of alcohol

Alcohol and cancer have a complex relationship. Alcohol causes cancers of the oesophagus, liver, breast, colon, oral cavity, rectum, pharynx, and larynx, and probably causes cancers of the pancreas. Cancer risk can occur even with light to moderate drinking. The more alcohol is consumed, the higher the cancer risk, and no amount can be considered completely safe.

Alcohol has a number of effects on health. Short-term effects of alcohol consumption include intoxication and dehydration. Long-term effects of alcohol include changes in the metabolism of the liver and brain, with increased risk of several types of cancer and alcohol use disorder. Alcohol intoxication affects the brain, causing slurred speech, clumsiness, and delayed reflexes. There is an increased risk of developing an alcohol use disorder for teenagers while their brain is still developing. Adolescents who drink have a higher probability of injury including death.

<span class="mw-page-title-main">Health effects of wine</span> Potential health effects resulting from drinking wine

The health effects of wine are mainly determined by its active ingredient – alcohol. Preliminary studies found that drinking small quantities of wine, particularly of red wine, may be associated with a decreased risk of cardiovascular diseases, cognitive decline, stroke, diabetes mellitus, metabolic syndrome, and early death. Other studies found no such effects.

Recommendations for consumption of the drug alcohol vary from recommendations to be alcohol-free to daily or weekly drinking "safe limits" or maximum intakes. Many governmental agencies and organizations have issued guidelines. These recommendations concerning maximum intake are distinct from any legal restrictions, for example countries with drunk driving laws or countries that have prohibited alcohol. To varying degrees, these recommendations are also distinct from the scientific evidence, such as the short-term and long-term effects of alcohol consumption.

The health effects of coffee include various possible health benefits and health risks.

<span class="mw-page-title-main">Alcoholic cardiomyopathy</span> Medical condition

Alcoholic cardiomyopathy (ACM) is a disease in which the long-term consumption of alcohol leads to heart failure. ACM is a type of dilated cardiomyopathy. The heart is unable to pump blood efficiently, leading to heart failure. It can affect other parts of the body if the heart failure is severe. It is most common in males between the ages of 35 and 50.

The Dietary Guidelines for Americans (DGA) provide nutritional advice for Americans who are healthy or who are at risk for chronic disease but do not currently have chronic disease. The Guidelines are published every five years by the US Department of Agriculture, together with the US Department of Health and Human Services. Notably, the most recent ninth edition for 2020–25 includes dietary guidelines for children from birth to 23 months. In addition to the Dietary Guidelines per se, there are additional tools for assessing diet and nutrition, including the Healthy Eating Index (HEI), which can be used to assess the quality of a given selection of foods in the context of the Dietary Guidelines. Also provided are additional explanations regarding customization of the Guidelines to individual eating preferences, application of the Guidelines during pregnancy and infancy, the USDA Nutrition Evidence Systematic Review, information about the Nutrition Communicators Network and the MyPlate initiative, information from the National Academies about redesigning the process by which the Dietary Guidelines for Americans are created, and information about dietary guidelines from other nations.

The impact of alcohol on aging is multifaceted. Evidence shows that alcoholism or alcohol abuse can cause both accelerated (or premature) aging – in which symptoms of aging appear earlier than normal – and exaggerated aging, in which the symptoms appear at the appropriate time but in a more exaggerated form. The effects of alcohol use disorder on the aging process include hypertension, cardiac dysrhythmia, cancers, gastrointestinal disorders, neurocognitive deficits, bone loss, and emotional disturbances especially depression. On the other hand, research also shows that drinking moderate amounts of alcohol may protect healthy adults from developing coronary heart disease. The American Heart Association cautions people not to start drinking, if you are not already drinking.

<span class="mw-page-title-main">Binge drinking</span> Form of excessive alcohol intake

Binge drinking, or heavy episodic drinking, is drinking alcoholic beverages with an intention of becoming intoxicated by heavy consumption of alcohol over a short period of time, but definitions vary considerably.

<span class="mw-page-title-main">Alcohol and breast cancer</span>

The relationship between alcohol and breast cancer is clear: drinking alcoholic beverages, including wine, beer, or liquor, is a risk factor for breast cancer, as well as some other forms of cancer. Drinking alcohol causes more than 100,000 cases of breast cancer worldwide every year. Globally, almost one in 10 cases of breast cancer is caused by women drinking alcoholic beverages. Drinking alcoholic beverages is among the most common modifiable risk factors.

<span class="mw-page-title-main">Alcohol (drug)</span> Active ingredient in fermented drinks

Alcohol, sometimes referred to by the chemical name ethanol, is the second most consumed psychoactive drug globally behind caffeine, and alcohol use disorders are the most prevalent of all substance use disorders worldwide. Alcohol is a central nervous system (CNS) depressant, decreasing electrical activity of neurons in the brain. The World Health Organization (WHO) classifies alcohol as a toxic, psychoactive, dependence-producing, and carcinogenic substance.

Alcohol-related brain damage alters both the structure and function of the brain as a result of the direct neurotoxic effects of alcohol intoxication or acute alcohol withdrawal. Increased alcohol intake is associated with damage to brain regions including the frontal lobe, limbic system, and cerebellum, with widespread cerebral atrophy, or brain shrinkage caused by neuron degeneration. This damage can be seen on neuroimaging scans.

<span class="mw-page-title-main">Alcohol packaging warning messages</span> Warning messages about health issues appearing on alcohol packaging

Alcohol packaging warning messages are warning messages that appear on the packaging of alcoholic drinks concerning their health effects. They have been implemented in an effort to enhance the public's awareness of the harmful effects of consuming alcoholic beverages, especially with respect to foetal alcohol syndrome and alcohol's carcinogenic properties. In general, warnings used in different countries try to emphasize the same messages. Such warnings have been required in alcohol advertising for many years, although the content of the warnings differ by nation.

References

  1. 1 2 "No level of alcohol consumption is safe for our health". www.who.int.
  2. 1 2 3 4 5 6 7 8 GBD 2020 Alcohol Collaboration (July 2022). "Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020". The Lancet. 400 (10347): 185–235. doi:10.1016/S0140-6736(22)00847-9. PMC   9289789 . PMID   35843246.{{cite journal}}: CS1 maint: numeric names: authors list (link)
  3. 1 2 3 National Institute on Alcohol Abuse and Alcoholism (NIAAA) (2000). Health risks and benefits of alcohol consumption (PDF). Vol. 24. pp. 5–11. doi:10.4135/9781412963855.n839. ISBN   9781412941860. PMC   6713002 . PMID   11199274. Archived from the original (PDF) on 2020-11-11. Retrieved 2006-07-31.{{cite book}}: |journal= ignored (help)
  4. Caan, Woody; Belleroche, Jackie de, eds. (11 April 2002). Drink, Drugs and Dependence: From Science to Clinical Practice (1st ed.). Routledge. pp.  19–20. ISBN   978-0-415-27891-1.
  5. Cargiulo T (March 2007). "Understanding the health impact of alcohol dependence". Am J Health Syst Pharm. 64 (5 Suppl 3): S5–11. doi:10.2146/ajhp060647. PMID   17322182.
  6. 1 2 Cheryl Platzman Weinstock (8 November 2017). "Alcohol Consumption Increases Risk of Breast and Other Cancers, Doctors Say". Scientific American . Retrieved 13 November 2018. In fact, alcohol consumption is known to increase the risk of several cancers, including head and neck, esophageal, liver, colorectal and female breast cancers.
  7. Müller D, Koch RD, von Specht H, Völker W, Münch EM (1985). "Neurophysiologic findings in chronic alcohol abuse". Psychiatr Neurol Med Psychol (Leipz) (in German). 37 (3): 129–132. PMID   2988001.
  8. Testino G (2008). "Alcoholic diseases in hepato-gastroenterology: a point of view". Hepatogastroenterology. 55 (82–83): 371–377. PMID   18613369.
  9. Stevenson JS (2005). "Alcohol use, misuse, abuse, and dependence in later adulthood". Annu Rev Nurs Res. 23: 245–280. doi:10.1891/0739-6686.23.1.245. PMID   16350768. S2CID   24586529.
  10. Guerri C, Pascual MA (2010). "Mechanisms involved in the neurotoxic, cognitive, and neurobehavioral effects of alcohol consumption during adolescence". Alcohol. 44 (1): 15–26. doi:10.1016/j.alcohol.2009.10.003. PMID   20113871.
  11. "Cancer warning labels to be included on alcohol in Ireland, minister confirms". Belfasttelegraph.co.uk. Belfast Telegraph. 26 September 2018.
  12. Cabot, R.C. (1904). "The relation of alcohol to arteriosclerosis". Journal of the American Medical Association. 43 (12): 774–775. doi:10.1001/jama.1904.92500120002a.
  13. 1 2 Schrieks IC, Heil AL, Hendriks HF, Mukamal KJ, Beulens JW (2015). "The effect of alcohol consumption on insulin sensitivity and glycemic status: a systematic review and meta-analysis of intervention studies". Diabetes Care. 38 (4): 723–732. doi: 10.2337/dc14-1556 . PMID   25805864. S2CID   32005728.
  14. Taylor B, Rehm J, Gmel G (2005). "Moderate alcohol consumption and the gastrointestinal tract". Dig Dis. 23 (3–4): 170–176. doi:10.1159/000090163. PMID   16508280. S2CID   30141003.
  15. 1 2 3 Fekjær, Hans Olav (December 2013). "Alcohol—a universal preventive agent? A critical analysis". Addiction. 108 (12): 2051–2057. doi: 10.1111/add.12104 . ISSN   0965-2140. PMID   23297738.
  16. Tsai, MK; Gao, W; Wen, CP (3 July 2023). "The relationship between alcohol consumption and health: J-shaped or less is more?". BMC Medicine. 21 (1): 228. doi: 10.1186/s12916-023-02911-w . PMC   10318728 . PMID   37400823.
  17. Di Castelnuovo, A.; Costanzo, S.; Bagnardi, V.; Donati, MB.; Iacoviello, L.; de Gaetano, G. (2006). "Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies". Arch Intern Med. 166 (22): 2437–45. doi:10.1001/archinte.166.22.2437. PMID   17159008.
  18. 1 2 Stockwell T, Zhao J, Panwar S, Roemer A, Naimi T, Chikritzhs T (2016). "Do "Moderate" Drinkers Have Reduced Mortality Risk? A Systematic Review and Meta-Analysis of Alcohol Consumption and All-Cause Mortality". J Stud Alcohol Drugs. 77 (2): 185–198. doi:10.15288/jsad.2016.77.185. PMC   4803651 . PMID   26997174.
  19. Tian, Y; Liu, J; Zhao, Y; Jiang, N; Liu, X; Zhao, G; Wang, X (7 June 2023). "Alcohol consumption and all-cause and cause-specific mortality among US adults: prospective cohort study". BMC Medicine. 21 (1): 208. doi: 10.1186/s12916-023-02907-6 . PMC   10249162 . PMID   37286970.
  20. GBD 2016 Alcohol Collaboration (September 2018). "Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016". The Lancet. 392 (10152): 1015–1035. doi:10.1016/S0140-6736(18)31310-2. PMC   6148333 . PMID   30146330.
  21. 1 2 3 O'Keefe, JH; Bhatti, SK; Bajwa, A; DiNicolantonio, JJ; Lavie, CJ (March 2014). "Alcohol and cardiovascular health: the dose makes the poison...or the remedy". Mayo Clinic Proceedings. 89 (3): 382–393. doi: 10.1016/j.mayocp.2013.11.005 . PMID   24582196.
  22. Klatsky Arthur L.; Udaltsova Natalia (2007). "Alcohol Drinking and Total Mortality Risk". Ann Epidemiol. 17 (5): 555. doi:10.1016/j.annepidem.2007.01.014.
  23. Lee, SJ.; Sudore, RL.; Williams, BA.; Lindquist, K.; Chen, HL.; Covinsky, KE. (Jun 2009). "Functional limitations, socioeconomic status, and all-cause mortality in moderate alcohol drinkers". J Am Geriatr Soc. 57 (6): 955–62. doi:10.1111/j.1532-5415.2009.02184.x. PMC   2847409 . PMID   19473456.
  24. Arriola, L.; Martinez-Camblor, P.; Larrañaga, N.; Basterretxea, M.; Amiano, P.; Moreno-Iribas, C.; Carracedo, R.; Agudo, A.; Ardanaz, E. (Jan 2010). "Alcohol intake and the risk of coronary heart disease in the Spanish EPIC cohort study". Heart. 96 (2): 124–30. doi: 10.1136/hrt.2009.173419 . hdl: 10668/316 . PMID   19933099. S2CID   10125924.
  25. Holahan, CJ.; Schutte, KK.; Brennan, PL.; Holahan, CK.; Moos, BS.; Moos, RH. (Nov 2010). "Late-life alcohol consumption and 20-year mortality". Alcohol Clin Exp Res. 34 (11): 1961–71. doi:10.1111/j.1530-0277.2010.01286.x. PMID   20735372.
  26. Stockwell, Tim; Zhao, Jinhui; Clay, James; Levesque, Christine; Sanger, Nitika; Sherk, Adam; Naimi, Timothy (30 January 2024). "Why do only some cohort studies find health benefits from low volume alcohol use? A systematic review and meta-analysis of study characteristics that may bias mortality risk estimates". Journal of Studies on Alcohol and Drugs. doi:10.15288/jsad.23-00283. PMID   38289182.
  27. van de Luitgaarden, IAT; van Oort, S; Bouman, EJ; Schoonmade, LJ; Schrieks, IC; Grobbee, DE; van der Schouw, YT; Larsson, SC; Burgess, S; van Ballegooijen, AJ; Onland-Moret, NC; Beulens, JWJ (July 2022). "Alcohol consumption in relation to cardiovascular diseases and mortality: a systematic review of Mendelian randomization studies". European Journal of Epidemiology. 37 (7): 655–669. doi:10.1007/s10654-021-00799-5. PMC   9329419 . PMID   34420153.
  28. Vogel, RA (2002). "Alcohol, heart disease, and mortality: a review". Rev Cardiovasc Med. 3 (1): 7–13. PMID   12439349.
  29. DeJong, William (29 December 2021). "The Moderate Alcohol and Cardiovascular Health Trial: Public health advocates should support good science, not undermine it". European Journal of Preventive Cardiology. 28 (15): e22–e24. doi:10.1177/2047487320915802. PMID   33611427.
  30. Oppenheimer, Gerald M.; Bayer, Ronald (5 December 2019). "Is Moderate Drinking Protective Against Heart Disease? The Science, Politics and History of a Public Health Conundrum". The Milbank Quarterly. 98 (1): 39–56. doi:10.1111/1468-0009.12437. PMC   7077768 . PMID   31803980.
  31. Martínez-González, Miguel A. "UNATI - A non-inferiority randomized trial testing an advice of moderate drinking pattern versus advice on abstention on major disease and mortality" (PDF). CORDIS | European Commission. doi:10.3030/101097681.
  32. El Khoudary, Samar R.; Aggarwal, Brooke; Beckie, Theresa M.; Hodis, Howard N.; Johnson, Amber E.; Langer, Robert D.; Limacher, Marian C.; Manson, JoAnn E.; Stefanick, Marcia L.; Allison, Matthew A. (22 December 2020). "Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association". Circulation. 142 (25): e506–e532. doi: 10.1161/CIR.0000000000000912 . PMID   33251828.
  33. Vardi, Moshe; Levy, Nina S.; Levy, Andrew P. (September 2013). "Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selection". Journal of Lipid Research. 54 (9): 2307–2314. doi: 10.1194/jlr.R026641 . PMC   3735930 . PMID   23505320.
  34. Yang, Jiaqi; Zhang, Yulin; Na, Xiaona; Zhao, Ai (18 March 2022). "β-Carotene Supplementation and Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials". Nutrients. 14 (6): 1284. doi: 10.3390/nu14061284 . PMC   8950884 . PMID   35334942.
  35. 1 2 Abdulla S (1997). "Is alcohol really good for you?". J R Soc Med. 90 (12): 651. doi:10.1177/014107689709001204. PMC   1296731 . PMID   9496287.
  36. Naimi TS, Brown DW, Brewer RD, et al. (2005). "Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults". Am J Prev Med. 28 (4): 369–373. doi:10.1016/j.amepre.2005.01.011. PMID   15831343.
  37. Casswell, Sally (April 2013). "Vested interests in addiction research and policy. Why do we not see the corporate interests of the alcohol industry as clearly as we see those of the tobacco industry?: Alcohol corporate interests compared with tobacco". Addiction. 108 (4): 680–685. doi:10.1111/add.12011. PMID   23496067.
  38. Sellman, D; Connor, J; Robinson, G; Jackson, R (2009). "Alcohol cardio-protection has been talked up" (PDF). N Z Med J. 122 (1303): 97–101. PMID   19851424.
  39. "New perspectives on how to formulate alcohol drinking guidelines". Alcohol in Moderation. ISFAR. December 2023. Retrieved 30 May 2024.
  40. Stockley, Creina S.; Hendriks, Henk F.J.; Ellison, R. Curtis (12 December 2023). "ISFAR reiterates its defence of moderate alcohol consumption's health benefits". Journal of Studies on Alcohol and Drugs. 85 (1): 136–140. doi:10.15288/jsad.23-00293. PMID   38095176.
  41. Stockwell, Tim; Chikritzhs, Tanya; Naimi, Timothy; Zhao, Jinhui (September 2016). "ISFAR Doth Protest Too Much: Another Attempt From Industry Sympathizers to Marginalize Scientific Skepticism About Alcohol's Hypothesized Health Benefits?". Journal of Studies on Alcohol and Drugs. 77 (5): 839–841. doi:10.15288/jsad.2016.77.839. PMID   27588546.
  42. "Alcohol Research Awash in Industry Money". Alcohol Justice. 2018. Retrieved 29 May 2024.
  43. Conibear, Helena (August 2014). "Response to Babor & Miller Editorial 'McCarthyism, conflict of interest and Addiction's new transparency declaration procedures'". Addiction. 109 (8): 1382–1383. doi:10.1111/add.12625. PMID   25041207.
  44. McCambridge, J; Hartwell, G (January 2015). "Has industry funding biased studies of the protective effects of alcohol on cardiovascular disease? A preliminary investigation of prospective cohort studies". Drug and Alcohol Review. 34 (1): 58–66. doi:10.1111/dar.12125. PMC   4441279 . PMID   24602075.
  45. Golder, S; McCambridge, J (November 2021). "Alcohol, cardiovascular disease and industry funding: A co-authorship network analysis of systematic reviews". Social Science & Medicine. 289: 114450. doi:10.1016/j.socscimed.2021.114450. PMC   8586735 . PMID   34607052.
  46. Sinkiewicz, W; Weglarz, M (2009). "Alcohol and wine and cardiovascular diseases in epidemiologic studies". Przegl Lek. 66 (5): 233–238. PMID   19739580.
  47. 1 2 Stockwell, Tim (4 August 2022). "How Several Hundred Lancet Co-Authors Lost a Million Global Alcohol-Caused Deaths". Movendi International.
  48. 1 2 "Alcohol". www.who.int. Retrieved 2024-03-18.
  49. "Global health estimates 2020: Leading causes of DALYs". World Health Organization. 2020.
  50. "Global health estimates 2020: Leading causes of death". World Health Organization. 2020.
  51. Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006 Dec 11–25;166(22) 2437-45.
  52. Wood AM, Kaptoge S, Butterworth AS, Willeit P, et al. (2018-04-14). "Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies". The Lancet. 391 (10129): 1513–1523. doi:10.1016/S0140-6736(18)30134-X. ISSN   0140-6736. PMC   5899998 . PMID   29676281.
  53. White, Ian R.; Altmann, Dan R.; Nanchahal, Kiran (27 July 2002). "Alcohol consumption and mortality: modelling risks for men and women at different ages". BMJ. 325 (7357): 191. doi:10.1136/bmj.325.7357.191. PMC   117446 . PMID   12142306.
  54. 1 2 Roy, A.; Prabhakaran, D.; Jeemon, P.; Thankappan, K.R.; Mohan, V.; Ramakrishnan, L.; Joshi, P.; Ahmed, F.; Mohan, B.V.; Saran, R.K.; Sinha, N.; Reddy, K.S. (26 February 2010). "Impact of alcohol on coronary heart disease in Indian men". Atherosclerosis. 210 (2): 531–535. doi:10.1016/j.atherosclerosis.2010.02.033. PMID   20226461.
  55. 1 2 IARC Alcohol causes more than half of all the premature deaths in Russian adults
  56. Tjønneland, A.; Christensen, J.; Olsen, A.; Stripp, C.; Thomsen, BL.; Overvad, K.; Peeters, PH.; van Gils, CH.; et al. (May 2007). "Alcohol intake and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC)". Cancer Causes Control. 18 (4): 361–73. doi:10.1007/s10552-006-0112-9. PMID   17364225. S2CID   21762284.
  57. Soerjomataram, I.; de Vries, E.; Coebergh, JW. (Sep 2009). "Did alcohol protect against death from breast cancer in Russia?". Lancet. 374 (9694): 975, author reply 975–6. doi: 10.1016/S0140-6736(09)61657-3 . PMID   19766875. S2CID   46431359.
  58. Joshi, Prashant; Islam, Shofiqul; Pais, Prem; Reddy, Srinath; Dorairaj, Prabhakaran; Kazmi, Khawar; Pandey, Mrigendra Raj; Haque, Sirajul; Mendis, Shanthi; Rangarajan, Sumathy; Yusuf, Salim (17 January 2007). "Risk Factors for Early Myocardial Infarction in South Asians Compared With Individuals in Other Countries". JAMA. 297 (3): 286–294. doi:10.1001/jama.297.3.286. PMID   17227980.
  59. "Alcohol Deaths: Rates stabilise in the UK". Statistics.gov.uk. Retrieved 2014-04-22.
  60. BBC Alcohol 'kills one in 20 Scots' 30 June 2009
  61. Sam Lister The price of alcohol: an extra 6,000 early deaths a year The Times, 19 October 2009
  62. White IR, Altmann DR, Nanchahal K (2000). "'Optimal' levels of alcohol consumption for men and women at different ages, and the all-cause mortality attributable to drinking" (PDF). London School of Hygiene and Tropical Medicine. Technical report. Archived from the original (PDF) on 2014-04-26. Retrieved 2014-04-25.
  63. "Alcohol and cancer". Cancer Research UK. 2013-08-22.
  64. Centers for Disease Control and Prevention Alcohol and Public Health
  65. McGinnis, J. Michael; Foege, William H. (1993). "Actual Causes of Death in the United States". JAMA. 270 (18): 2207–2212. doi:10.1001/jama.270.18.2207. PMID   8411605.
  66. "Alcohol-Attributable Deaths and Years of Potential Life Lost — United States, 2001". Centers for Disease Control and Prevention. 2004-09-24.
  67. "Alcohol-Related Deaths in the U.S. More than Double from 1999 to 2020". www.fau.edu. Retrieved 2024-11-30.
  68. Matarazzo, Alexandra; Hennekens, Charles H.; Dunn, John; Benson, Katerina; Willett, Yanna; Levine, Robert S.; Mejia, Maria Carmenza; Kitsantas, Panagiota (2024). "New Clinical and Public Health Challenges: Increasing Trends in United States Alcohol Related Mortality". The American Journal of Medicine. doi:10.1016/j.amjmed.2024.10.024.
  69. Mennen LI, Balkau B, Vol S, Cacès E, Eschwège E (1999). "Fibrinogen: a possible link between alcohol consumption and cardiovascular disease? DESIR Study Group". Arterioscler Thromb Vasc Biol. 19 (4): 887–892. doi:10.1161/01.atv.19.4.887. PMID   10195914. Archived from the original on 2013-01-12. Retrieved 2009-01-10.
  70. Pahor M, Guralnik JM, Havlik RJ, et al. (1996). "Alcohol consumption and risk of deep venous thrombosis and pulmonary embolism in older persons". J Am Geriatr Soc. 44 (9): 1030–1037. doi:10.1111/j.1532-5415.1996.tb02933.x. PMID   8790226. S2CID   11553439.
  71. Rimm, EB; Williams, P; Fosher, K; Criqui, M; Stampfer, MJ (1999). "Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors". BMJ. 319 (7224): 1523–1528. doi:10.1136/bmj.319.7224.1523. PMC   28294 . PMID   10591709.
  72. Brien Susan E, Ronksley Paul E, Turner Barbara J, Mukamal Kenneth J, Ghali William A (2011). "Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies". BMJ. 342: d636. doi:10.1136/bmj.d636. PMC   3043110 . PMID   21343206.
  73. Costanzo S, Di Castelnuovo A, Donati MB, Iacoviello L, de Gaetano G (2010). "Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis". J. Am. Coll. Cardiol. 55 (13): 1339–1347. doi:10.1016/j.jacc.2010.01.006. PMID   20338495.
  74. Albert, MA; Glynn, RJ; Ridker, PM (2003). "Alcohol consumption and plasma concentration of C-reactive protein". Circulation. 107 (3): 443–447. doi: 10.1161/01.CIR.0000045669.16499.EC . PMID   12551869. S2CID   323583.
  75. Stewart, SH; Mainous, AG; Gilbert, G (2002). "Relation between alcohol consumption and C-reactive protein levels in the adult US population" (PDF). J Am Board Fam Pract. 15 (6): 437–442. PMID   12463288.
  76. Imhof, A; Froehlich, M; Brenner, H; Boeing, H; Pepys, MB; Koenig, W. (2001). "Effect of alcohol consumption on systemic markers of inflammation". Lancet. 357 (9258): 763–767. doi:10.1016/S0140-6736(00)04170-2. PMID   11253971. S2CID   8046780.
  77. Sesso HD, Stampfer MJ, Rosner B, Hennekens CH, Manson JE, Gaziano JM (2000). "Seven-Year Changes in Alcohol Consumption and Subsequent Risk of Cardiovascular Disease in Men". Arch Intern Med. 160 (17): 2605–2612. doi:10.1001/archinte.160.17.2605. PMID   10999974.
  78. Camargo CA, Stampfer MJ, Glynn RJ, et al. (1997). "Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians". Circulation. 95 (3): 577–580. doi:10.1161/01.cir.95.3.577. PMID   9024142. Archived from the original on 2011-02-12. Retrieved 2006-07-25.
  79. Vliegenthart R, Geleijnse JM, Hofman A, et al. (2002). "Alcohol consumption and risk of peripheral arterial disease: the Rotterdam study". Am J Epidemiol. 155 (4): 332–338. doi: 10.1093/aje/155.4.332 . hdl: 1765/9842 . PMID   11836197.
  80. Mingardi R, Avogaro A, Noventa F, et al. (1997). "Alcohol intake is no longer associated with a lower prevalence of peripheral vascular disease in non-insulin dependent diabetic women". Nutrition Metabolism and Cardiovascular Disease. 7 (4): 301–308.
  81. Djoussé L, Levy D, Murabito JM, Cupples LA, Ellison RC (2000). "Alcohol consumption and risk of intermittent claudication in the Framingham Heart Study". Circulation. 102 (25): 3092–3097. doi: 10.1161/01.cir.102.25.3092 . PMID   11120700. S2CID   1586122.
  82. Muntwyler J, Hennekens CH, Buring JE, Gaziano JM (1998). "Mortality and light to moderate alcohol consumption after myocardial infarction". Lancet. 352 (9144): 1882–1885. doi:10.1016/S0140-6736(98)06351-X. PMID   9863785. S2CID   54365788.
  83. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA (2001). "Prior alcohol consumption and mortality following acute myocardial infarction". JAMA. 285 (15): 1965–1970. doi:10.1001/jama.285.15.1965. PMID   11308432.
  84. "Alcohol helps reduce damage after heart attacks". Newswise.com. 2004-08-30. Retrieved 2014-04-22.
  85. Djoussé L, Gaziano JM (2008). "Alcohol consumption and heart failure: a systematic review". Curr Atheroscler Rep. 10 (2): 117–120. doi:10.1007/s11883-008-0017-z. PMC   2365733 . PMID   18417065.
  86. Kloner RA, Rezkalla SH (2007). "To drink or not to drink? That is the question". Circulation. 116 (11): 1306–1317. doi: 10.1161/CIRCULATIONAHA.106.678375 . PMID   17846344.
  87. Saremi A, Arora R (2008). "The cardiovascular implications of alcohol and red wine". Am J Ther. 15 (3): 265–277. doi:10.1097/MJT.0b013e3180a5e61a. PMID   18496264. S2CID   7243756.
  88. Roerecke M, Kaczorowski J, Tobe SW, Gmel G, Hasan OS, Rehm J (2017). "The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis". Lancet Public Health. 2 (2): e108–e120. doi:10.1016/S2468-2667(17)30003-8. PMC   6118407 . PMID   29253389.
  89. Awtry, EH; Philippides, GJ (2010). "Alcoholic and cocaine-associated cardiomyopathies". Prog Cardiovasc Dis. 52 (4): 289–299. doi:10.1016/j.pcad.2009.11.004. PMID   20109599.
  90. Savage D, Lindenbaum J (1986). "Anemia in alcoholics". Medicine (Baltimore). 65 (5): 322–338. doi: 10.1097/00005792-198609000-00005 . PMID   3747828. S2CID   25790752.
  91. Ballard, Harold S. (1997). "The Hematological Complications of Alcoholism" (PDF). Alcohol Health & Research World . 21 (1): 44. PMC   6826798 . PMID   15706762. Archived from the original (PDF) on 2021-09-14. Retrieved 2020-10-22.
  92. Larsson, SC; Drca, N; Wolk, A (2014). "Alcohol Consumption and Risk of Atrial Fibrillation". Journal of the American College of Cardiology. 64 (3): 281–289. doi: 10.1016/j.jacc.2014.03.048 . PMID   25034065. S2CID   22236791.
  93. Panza F, Capurso C, D'Introno A, et al. (2008). "Vascular risk factors, alcohol intake, and cognitive decline". J Nutr Health Aging. 12 (6): 376–81. doi: 10.1007/BF02982669 . PMID   18548174. S2CID   3123226.
  94. Panza, F.; Capurso, C.; D'Introno, A.; Colacicco, AM.; Frisardi, V.; Lorusso, M.; Santamato, A.; Seripa, D.; et al. (May 2009). "Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes". J Alzheimers Dis. 17 (1): 7–31. doi:10.3233/JAD-2009-1009. PMID   19494429.
  95. Verbaten, MN. (Apr 2009). "Chronic effects of low to moderate alcohol consumption on structural and functional properties of the brain: beneficial or not?". Hum Psychopharmacol. 24 (3): 199–205. doi:10.1002/hup.1022. PMID   19330800. S2CID   205924421.
  96. Bleich S, Bleich K, Kropp S, et al. (2001). "Moderate alcohol consumption in social drinkers raises plasma homocysteine levels: a contradiction to the 'French Paradox'?". Alcohol Alcohol. 36 (3): 189–92. doi: 10.1093/alcalc/36.3.189 . PMID   11373253.
  97. Bleich S, Carl M, Bayerlein K, et al. (March 2005). "Evidence of increased homocysteine levels in alcoholism: the Franconian alcoholism research studies (FARS)". Alcohol. Clin. Exp. Res. 29 (3): 334–6. doi:10.1097/01.alc.0000156083.91214.59. PMID   15770107.
  98. Bleich S, Degner D, Bandelow B, von Ahsen N, Rüther E, Kornhuber J (August 2000). "Plasma homocysteine is a predictor of alcohol withdrawal seizures". NeuroReport. 11 (12): 2749–52. doi:10.1097/00001756-200008210-00028. PMID   10976956. S2CID   20270541.
  99. Bleich S, Bandelow B, Javaheripour K, et al. (January 2003). "Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholism". Neurosci. Lett. 335 (3): 179–82. doi:10.1016/S0304-3940(02)01194-1. PMID   12531462. S2CID   33032529.
  100. Wilhelm J, Bayerlein K, Hillemacher T, et al. (March 2006). "Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with alcoholism". J Neural Transm. 113 (3): 357–63. doi:10.1007/s00702-005-0333-1. PMID   15997414. S2CID   11980558.
  101. Di Castelnuovo, A.; Costanzo, S.; di Giuseppe, R.; de Gaetano, G.; Iacoviello, L. (Sep 2009). "Alcohol consumption and cardiovascular risk: mechanisms of action and epidemiologic perspectives". Future Cardiol. 5 (5): 467–77. doi:10.2217/fca.09.36. PMID   19715411.
  102. Klatsky, AL. (May 2009). "Alcohol and cardiovascular diseases". Expert Rev Cardiovasc Ther. 7 (5): 499–506. doi:10.1586/erc.09.22. PMID   19419257. S2CID   23782870.
  103. Galimanis, A.; Mono, ML.; Arnold, M.; Nedeltchev, K.; Mattle, HP. (Feb 2009). "Lifestyle and stroke risk: a review". Current Opinion in Neurology. 22 (1): 60–8. doi:10.1097/WCO.0b013e32831fda0e. PMID   19155763. S2CID   22619761.
  104. O'Keefe, JH.; Bybee, KA.; Lavie, CJ. (Sep 2007). "Alcohol and cardiovascular health: the razor-sharp double-edged sword". J Am Coll Cardiol. 50 (11): 1009–14. doi: 10.1016/j.jacc.2007.04.089 . PMID   17825708. S2CID   42462804.
  105. "Stroke Risk Reduction – Alcohol Use – National Stroke Association". Stroke.org. Retrieved 2014-04-22.
  106. Emberson, JR.; Bennett, DA. (2006). "Effect of alcohol on risk of coronary heart disease and stroke: causality, bias, or a bit of both?". Vasc Health Risk Manag. 2 (3): 239–49. doi: 10.2147/vhrm.2006.2.3.239 . PMC   1993990 . PMID   17326330.
  107. Neiman, J. (Oct 1998). "Alcohol as a risk factor for brain damage: neurologic aspects". Alcohol Clin Exp Res. 22 (7 Suppl): 346S–351S. doi:10.1111/j.1530-0277.1998.tb04389.x. PMID   9799959.
  108. Heffernan, TM (2008). "The impact of excessive alcohol use on prospective memory: a brief review". Curr Drug Abuse Rev. 1 (1): 36–41. doi:10.2174/1874473710801010036. PMID   19630703.
  109. Pierucci-Lagha A, Derouesné C (2003). "Alcoholism and aging. 2. Alcoholic dementia or alcoholic cognitive impairment?". Psychol Neuropsychiatr Vieil (in French). 1 (4): 237–249. PMID   15683959.
  110. Peters R, Peters J, Warner J, Beckett N, Bulpitt C (2008). "Alcohol, dementia and cognitive decline in the elderly: a systematic review". Age Ageing. 37 (5): 505–512. doi: 10.1093/ageing/afn095 . PMID   18487267.
  111. Cooper C, Bebbington P, Meltzer H, Jenkins R, Brugha T, Lindesay J, Livingston G (2009). "Alcohol in moderation, premorbid intelligence and cognition In Older Adults: results from the Psychiatric Morbidity Survey". J Neurol Neurosurg Psychiatry. 80 (11): 1236–1239. doi:10.1136/jnnp.2008.163964. PMID   19620140. S2CID   9226226.
  112. Martin PR, Singleton CK, Hiller-Sturmhöfel S (2003). "The role of thiamine deficiency in alcoholic brain disease". Alcohol Res Health. 27 (2): 134–142. PMC   6668887 . PMID   15303623.
  113. Butters N (1981). "The Wernicke-Korsakoff syndrome: a review of psychological, neuropathological and etiological factors". Curr Alcohol. 8: 205–232. PMID   6806017.
  114. Jeffrey E Kelsey; D Jeffrey Newport & Charles B Nemeroff (2006). "Alcohol Use Disorders". Principles of Psychopharmacology for Mental Health Professionals. Wiley-Interscience. pp. 196–197. ISBN   978-0-471-79462-2.
  115. Merle A. Carter & Edward Bernstein (2005). "Acute and Chronic Alcohol Intoxication". In Elizabeth Mitchell & Ron Medzon (eds.). Introduction to Emergency Medicine. Lippincott Williams & Wilkins. p. 272. ISBN   978-0-7817-3200-0.
  116. Bain PG, Findley LJ, Thompson PD, et al. (August 1994). "A study of hereditary essential tremor". Brain. 117 (Pt 4): 805–24. doi:10.1093/brain/117.4.805. PMID   7922467.
    Lou JS, Jankovic J (February 1991). "Essential tremor: clinical correlates in 350 patients". Neurology. 41 (2 (Pt 1)): 234–8. doi:10.1212/WNL.41.2_Part_1.234. PMID   1992367. S2CID   20531450.
    Wasielewski PG, Burns JM, Koller WC (1998). "Pharmacologic treatment of tremor". Mov. Disord. 13 (Suppl 3): 90–100. doi:10.1002/mds.870131316. PMID   9827602. S2CID   21004382.
    Boecker H, Wills AJ, Ceballos-Baumann A, et al. (May 1996). "The effect of ethanol on alcohol-responsive essential tremor: a positron emission tomography study". Annals of Neurology. 39 (5): 650–8. doi:10.1002/ana.410390515. PMID   8619551. S2CID   11083928.
    "Setting a steady course for benign essential tremor". Johns Hopkins Med Lett Health After 50. 11 (10): 3. December 1999. PMID   10586714.
  117. Mostile, G.; Jankovic, J. (2010). "Alcohol in essential tremor and other movement disorders". Movement Disorders. 25 (14): 2274–2284. doi:10.1002/mds.23240. PMID   20721919. S2CID   39981956.
  118. Iseri, P. K.; Karson, A.; Gullu, K. M.; Akman, O.; Kokturk, S.; Yardýmoglu, M.; Erturk, S.; Ates, N. (2011). "The effect of memantine in harmaline-induced tremor and neurodegeneration". Neuropharmacology. 61 (4): 715–723. doi:10.1016/j.neuropharm.2011.05.015. PMID   21640732. S2CID   16296043.
  119. Miwa, H. (2007). "Rodent models of tremor". The Cerebellum. 6 (1): 66–72. doi:10.1080/14734220601016080. PMID   17366267. S2CID   24179439.
  120. Lee-chiong, Teofilo (24 April 2008). Sleep Medicine: Essentials and Review. Oxford University Press, USA. p. 105. ISBN   978-0-19-530659-0.
  121. Fergusson DM, Boden JM, Horwood LJ (March 2009). "Tests of causal links between alcohol abuse or dependence and major depression". Arch. Gen. Psychiatry. 66 (3): 260–6. doi:10.1001/archgenpsychiatry.2008.543. PMID   19255375.
  122. Chignon JM, Cortes MJ, Martin P, Chabannes JP (1998). "Tentative de suicide et dépendance alcoolique : résultats d'une enquête épidémiologique" [Attempted suicide and alcohol dependence: results of an epidemiologic survey]. Encephale (in French). 24 (4): 347–54. PMID   9809240.
  123. Ayd, Frank J. (31 May 2000). Lexicon of psychiatry, neurology, and the neurosciences. Philadelphia: Lippincott-Williams Wilkins. p. 349. ISBN   978-0-7817-2468-5.
  124. Harned, Melanie S.; Najavits, Lisa M.; Weiss, Roger D. (January 2006). "Self-Harm and Suicidal Behavior in Women with Comorbid PTSD and Substance Dependence". American Journal on Addictions. 15 (5): 392–395. doi:10.1080/10550490600860387. ISSN   1055-0496. PMID   16966196.
  125. Appleby, Louis; Duffy, David; Ryan, Tony (25 Aug 2004). New Approaches to Preventing Suicide: A Manual For Practitioners. Jessica Kingsley Publishers. pp. 31–32. ISBN   978-1-84310-221-2.
  126. Uekermann J, Daum I (May 2008). "Social cognition in alcoholism: a link to prefrontal cortex dysfunction?". Addiction. 103 (5): 726–35. doi:10.1111/j.1360-0443.2008.02157.x. PMID   18412750.
  127. Jasova D, Bob P, Fedor-Freybergh P (December 2007). "Alcohol craving, limbic irritability, and stress". Med. Sci. Monit. 13 (12): CR543–7. PMID   18049433 . Retrieved 2008-05-13.
  128. Young R, Sweeting H, West P (2008). "A longitudinal study of alcohol use and antisocial behaviour in young people". Alcohol Alcohol. 43 (2): 204–14. doi:10.1093/alcalc/agm147. PMC   2367698 . PMID   17977868.
  129. Marinkovic K; Oscar-Berman M; Urban T; O'Reilly CE; Howard JA; Sawyer K; Harris GJ (November 2009). "Alcoholism and dampened temporal limbic activation to emotional faces". Alcohol Clin Exp Res. 33 (11): 1880–92. doi:10.1111/j.1530-0277.2009.01026.x. PMC   3543694 . PMID   19673745.
  130. Wetterling T; Junghanns K (December 2000). "Psychopathology of alcoholics during withdrawal and early abstinence". Eur Psychiatry. 15 (8): 483–8. doi:10.1016/S0924-9338(00)00519-8. PMID   11175926. S2CID   24094651.
  131. Cowley DS (24 January 1992). "Alcohol abuse, substance abuse, and panic disorder". Am J Med. 92 (1A): 41S–8S. doi:10.1016/0002-9343(92)90136-Y. PMID   1346485.
  132. Cosci F; Schruers KR; Abrams K; Griez EJ (June 2007). "Alcohol use disorders and panic disorder: a review of the evidence of a direct relationship". J Clin Psychiatry. 68 (6): 874–80. doi:10.4088/JCP.v68n0608. PMID   17592911.
  133. 1 2 Alcohol-Related Psychosis at eMedicine
  134. Tien AY, Anthony JC (August 1990). "Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences". J. Nerv. Ment. Dis. 178 (8): 473–80. doi:10.1097/00005053-199017880-00001. PMID   2380692.
  135. "A wine a day ... keeps the psychiatrist away? Light drinking linked to lower risk of depression". ScienceDaily. Retrieved 2014-04-22.
  136. Terra MB, Figueira I, Barros HM (August 2004). "Impact of alcohol intoxication and withdrawal syndrome on social phobia and panic disorder in alcoholic inpatients". Rev Hosp Clin Fac Med Sao Paulo. 59 (4): 187–92. doi: 10.1590/S0041-87812004000400006 . PMID   15361983.
  137. Cohen SI (February 1995). "Alcohol and benzodiazepines generate anxiety, panic and phobias". J R Soc Med. 88 (2): 73–7. PMC   1295099 . PMID   7769598.
  138. McClure EA, Gipson CD, Malcolm RJ, Kalivas PW, Gray KM (2014). "Potential role of N-acetylcysteine in the management of substance use disorders". CNS Drugs. 28 (2): 95–106. doi:10.1007/s40263-014-0142-x. PMC   4009342 . PMID   24442756.
  139. Greenfield, Shelly F.; Weiss, Roger D.; Muenz, Larry R.; Vagge, Lisa M.; Kelly, John F.; Bello, Lisa R.; Michael, Jacqueline (1998-03-01). "The Effect of Depression on Return to Drinking: A Prospective Study". Archives of General Psychiatry. 55 (3): 259–265. doi:10.1001/archpsyc.55.3.259. ISSN   0003-990X. PMID   9510220.
  140. Cordain L, Bryan ED, Melby CL, Smith MJ (1 April 1997). "Influence of moderate daily wine consumption on body weight regulation and metabolism in healthy free-living males". J Am Coll Nutr. 16 (2): 134–9. doi:10.1080/07315724.1997.10718663. PMID   9100213. Archived from the original on 23 February 2007.
  141. Arif AA, Rohrer JE (2005). "Patterns of alcohol drinking and its association with obesity: data from the Third National Health and Nutrition Examination Survey, 1988–1994". BMC Public Health. 5 (1): 126. doi: 10.1186/1471-2458-5-126 . PMC   1318457 . PMID   16329757.
  142. Bode C, Bode JC (1997). "Alcohol's role in gastrointestinal tract disorders" (PDF). Alcohol Health Res World. 21 (1): 76–83. PMC   6826790 . PMID   15706765. Archived from the original (PDF) on 2006-09-02.
  143. Freiberg MS, Cabral HJ, Heeren TC, Vasan RS, Curtis Ellison R (2004). "Alcohol consumption and the prevalence of the Metabolic Syndrome in the US.: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey". Diabetes Care. 27 (12): 2954–2959. doi:10.2337/diacare.27.12.2954. PMID   15562213.
  144. Yoon YS, Oh SW, Baik HW, Park HS, Kim WY (2004). "Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey". Am J Clin Nutr. 80 (1): 217–224. doi: 10.1093/ajcn/80.1.217 . PMID   15213051.
  145. La Vecchia C, Decarli A, Ferraroni M, Negri E (September 1994). "Alcohol drinking and prevalence of self-reported gallstone disease in the 1983 Italian National Health Survey". Epidemiology. 5 (5): 533–6. JSTOR   3702209. PMID   7986868.
  146. Leitzmann MF, Giovannucci EL, Stampfer MJ, et al. (May 1999). "Prospective study of alcohol consumption patterns in relation to symptomatic gallstone disease in men". Alcohol Clin Exp Res. 23 (5): 835–41. doi:10.1111/j.1530-0277.1999.tb04191.x. PMID   10371403.
  147. Sahi T, Paffenbarger RS, Hsieh CC, Lee IM (1 April 1998). "Body mass index, cigarette smoking, and other characteristics as predictors of self-reported, physician-diagnosed gallbladder disease in male college alumni". Am J Epidemiol. 147 (7): 644–51. doi: 10.1093/oxfordjournals.aje.a009505 . PMID   9554603.
  148. Simon JA, Grady D, Snabes MC, Fong J, Hunninghake DB (March 1998). "Ascorbic acid supplement use and the prevalence of gallbladder disease. Heart & Estrogen-Progestin Replacement Study (HERS) Research Group". J Clin Epidemiol. 51 (3): 257–65. doi:10.1016/S0895-4356(97)80280-6. PMID   9495691.
  149. 1 2 Barve A, Khan R, Marsano L, Ravindra KV, McClain C (2008). "Treatment of alcoholic liver disease" (PDF). Ann Hepatol. 7 (1): 5–15. doi:10.1016/S1665-2681(19)31883-6. PMID   18376362.
  150. Fehér J, Lengyel G (December 2008). "Silymarin in the treatment of chronic liver diseases: past and future". Orv Hetil (in Hungarian). 149 (51): 2413–8. doi:10.1556/OH.2008.28519. PMID   19073452.
  151. Voigt MD (February 2005). "Alcohol in hepatocellular cancer". Clin Liver Dis. 9 (1): 151–69. doi:10.1016/j.cld.2004.10.003. PMID   15763234.
  152. Morgan TR, Mandayam S, Jamal MM (November 2004). "Alcohol and hepatocellular carcinoma". Gastroenterology. 127 (5 Suppl 1): S87–96. doi: 10.1053/j.gastro.2004.09.020 . PMID   15508108.
  153. Frossard JL, Steer ML, Pastor CM (January 2008). "Acute pancreatitis". Lancet. 371 (9607): 143–52. doi:10.1016/S0140-6736(08)60107-5. PMID   18191686.
  154. Bachmann K, Mann O, Izbicki JR, Strate T (November 2008). "Chronic pancreatitis--a surgeons' view". Med. Sci. Monit. 14 (11): RA198–205. PMID   18971885.
  155. Nair RJ, Lawler L, Miller MR (December 2007). "Chronic pancreatitis". Am Fam Physician. 76 (11): 1679–88. PMID   18092710.
  156. Tattersall SJ, Apte MV, Wilson JS (July 2008). "A fire inside: current concepts in chronic pancreatitis". Intern Med J. 38 (7): 592–8. doi: 10.1111/j.1445-5994.2008.01715.x . PMID   18715303. S2CID   205502466.
  157. Molina PE, Gardner JD, Souza-Smith FM, Whitaker AM (2014). "Alcohol abuse: critical pathophysiological processes and contribution to disease burden". Physiology. 29 (3): 203–215. doi:10.1152/physiol.00055.2013. PMC   4046814 . PMID   24789985.
  158. Mello, Fernanda Weber; Melo, Gilberto; Pasetto, Júlia Jacoby; Silva, Carolina Amália Barcellos; Warnakulasuriya, Saman; Rivero, Elena Riet Correa (July 2019). "The synergistic effect of tobacco and alcohol consumption on oral squamous cell carcinoma: a systematic review and meta-analysis". Clinical Oral Investigations. 23 (7): 2849–2859. doi:10.1007/s00784-019-02958-1. ISSN   1432-6981. PMID   31111280. S2CID   159040972.
  159. Singhavi, Hitesh Rajendra; Singh, Arjun; Bhattacharjee, Atanu; Talole, Sanjay; Dikshit, Rajesh; Chaturvedi, Pankaj (April 2020). "Alcohol and cancer risk: A systematic review and meta-analysis of prospective Indian studies". Indian Journal of Public Health. 64 (2): 186–190. doi: 10.4103/ijph.IJPH_529_19 . ISSN   0019-557X. PMID   32584303.
  160. Ustrell-Borràs, M.; Traboulsi-Garet, B.; Gay-Escoda, C. (2020-01-01). "Alcohol-based mouthwash as a risk factor of oral cancer: A systematic review". Medicina Oral, Patologia Oral y Cirugia Bucal. 25 (1): e1–e12. doi:10.4317/medoral.23085. ISSN   1698-6946. PMC   6982979 . PMID   31655832.
  161. Wang, Jiantao; Lv, Jian; Wang, Wanchun; Jiang, Xiubo (July 2016). "Alcohol consumption and risk of periodontitis: a meta-analysis". Journal of Clinical Periodontology. 43 (7): 572–583. doi:10.1111/jcpe.12556. ISSN   1600-051X. PMID   27029013.
  162. Traphagen, Nicole; Tian, Zhi; Allen-Gipson, Diane (2015-10-20). "Chronic Ethanol Exposure: Pathogenesis of Pulmonary Disease and Dysfunction". Biomolecules. 5 (4): 2840–2853. doi: 10.3390/biom5042840 . ISSN   2218-273X. PMC   4693259 . PMID   26492278.
  163. Kershaw, Guidot, Corey D., David M. (2008). "Alcoholic lung disease". Alcohol Research & Health . 31 (1): 66–75. PMC   3860447 . PMID   23584753 via U.S. Government Printing Office.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  164. Gregg, Valerie (2008). "The Hidden Truth about Alcohol". Emory University School of Medicine . Archived from the original on October 31, 2008. Retrieved October 22, 2020.
  165. Doll R, Peto R, Boreham J, Sutherland I (February 2005). "Mortality in relation to alcohol consumption: a prospective study among male British doctors". Int J Epidemiol. 34 (1): 199–204. doi: 10.1093/ije/dyh369 . PMID   15647313.
  166. Hirvonen T, Pietinen P, Virtanen M, Albanes D, Virtamo J (1999). "Nutrient intake and use of beverages and the risk of kidney stones among male smokers". Am J Epidemiol. 150 (2): 187–194. doi: 10.1093/oxfordjournals.aje.a009979 . PMID   10412964. S2CID   10690400.
  167. Soucie JM, Coates RJ, McClellan W, Austin H, Thun M (1996). "Relation between geographic variability in kidney stones prevalence and risk factors for stones". Am J Epidemiol. 143 (5): 487–495. doi: 10.1093/oxfordjournals.aje.a008769 . PMID   8610664.
  168. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ (1996). "Prospective study of beverage use and the risk of kidney stones". Am J Epidemiol. 143 (3): 240–247. doi: 10.1093/oxfordjournals.aje.a008734 . PMID   8561157.
  169. Curhan GC, Willett WC, Speizer FE, Stampfer MJ (1998). "Beverage use and risk for kidney stones in women". Annals of Internal Medicine. 128 (7): 534–540. doi:10.7326/0003-4819-128-7-199804010-00003. PMID   9518397. S2CID   43163872.
  170. Allen, Mark S; Walter, Emma E (2018). "Health-Related Lifestyle Factors and Sexual Dysfunction: A Meta-Analysis of Population-Based Research". The Journal of Sexual Medicine. 15 (4): 458–475. doi:10.1016/j.jsxm.2018.02.008. PMID   29523476.
  171. Cheng, J Y W; Ng, E M L; Chen, R Y L; Ko, J S N (2007). "Alcohol consumption and erectile dysfunction: meta-analysis of population-based studies". International Journal of Impotence Research. 19 (4): 343–352. doi: 10.1038/sj.ijir.3901556 . PMID   17538641.
  172. Wang, Xiao-Ming; Bai, Yun-Jin; Yang, Yu-Bo; Li, Jin-Hong; Tang, Yin; Han, Ping (2018). "Alcohol intake and risk of erectile dysfunction: a dose-response meta-analysis of observational studies". International Journal of Impotence Research. 30 (6): 342–351. doi:10.1038/s41443-018-0022-x. PMID   30232467. S2CID   52300588.
  173. Jiann, Bang-Ping (2010). "Effect of Alcohol Consumption on the Risk of Erectile Dysfunction" (PDF). Urol Sci. 21 (4): 163–168. doi: 10.1016/S1879-5226(10)60037-1 .
  174. Frias, J; Torres, JM; Miranda, MT; Ruiz, E; Ortega, E (2002). "Effects of acute alcohol intoxication on pituitary-gonadal axis hormones, pituitary-adrenal axis hormones, beta-endorphin and prolactin in human adults of both sexes". Alcohol and Alcoholism . 37 (2): 169–73. doi: 10.1093/alcalc/37.2.169 . PMID   11912073.
  175. Mendelson, JH; Ellingboe, J; Mello, NK; Kuehnle, John (1978). "Effects of Alcohol on Plasma Testosterone and Luteinizing Hormone Levels". Alcoholism: Clinical and Experimental Research . 2 (3): 255–8. doi:10.1111/j.1530-0277.1978.tb05808.x. PMID   356646.
  176. Mendelson, JH; Mello, NK; Ellingboe, J (1977). "Effects of acute alcohol intake on pituitary-gonadal hormones in normal human males". Journal of Pharmacology and Experimental Therapeutics . 202 (3): 676–82. PMID   894528.
  177. Sarkola, T; Eriksson, CJP (2003). "Testosterone Increases in Men After a Low Dose of Alcohol". Alcoholism: Clinical and Experimental Research . 27 (4): 682–685. doi:10.1111/j.1530-0277.2003.tb04405.x. PMID   12711931.
  178. Emanuele, MA; Halloran, MM; Uddin, S; Tentler, JJ; Emanuele, NV; Lawrence, AM; Kelly, MR (1993). "The effects of alcohol on the neuroendocrine control of reproduction". In Zakhari, S (ed.). Alcohol and the Endocrine System. National Institute of Health Publications. pp. 89–116. NIH Pub 93-3533.
  179. Ellingboe, J; Varanelli, CC (1979). "Ethanol inhibits testosterone biosynthesis by direct action on Leydig cells". Research Communications in Chemical Pathology and Pharmacology . 24 (1): 87–102. PMID   219455.
  180. Taniguchi N, Kaneko S (November 1997). "Alcoholic effect on male sexual function". Nippon Rinsho (in Japanese). 55 (11): 3040–4. PMID   9396310.
  181. Yoshitsugu M, Ihori M (November 1997). "Endocrine disturbances in liver cirrhosis—focused on sex hormones". Nippon Rinsho (in Japanese). 55 (11): 3002–6. PMID   9396303.
  182. Fentiman, IS.; Fourquet, A.; Hortobagyi, GN. (Feb 2006). "Male breast cancer". Lancet. 367 (9510): 595–604. doi:10.1016/S0140-6736(06)68226-3. PMID   16488803. S2CID   21618414.
  183. Gavaler, JS. (1998). "Alcoholic beverages as a source of estrogens". Alcohol Health Res World. 22 (3): 220–7. PMC   6761902 . PMID   15706799.
  184. 1 2 Weiss, JR.; Moysich, KB.; Swede, H. (Jan 2005). "Epidemiology of male breast cancer". Cancer Epidemiol Biomarkers Prev. 14 (1): 20–6. doi: 10.1158/1055-9965.20.14.1 . PMID   15668471. S2CID   9667914.
  185. Boffetta, P.; Hashibe, M. (Feb 2006). "Alcohol and cancer". Lancet Oncol. 7 (2): 149–56. doi:10.1016/S1470-2045(06)70577-0. PMID   16455479.
  186. Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, Rehm J (2009). "Alcohol as a Risk Factor for Type 2 Diabetes". Diabetes Care. 32 (11): 2123–2132. doi:10.2337/dc09-0227. PMC   2768203 . PMID   19875607.
  187. Carlsson S, Hammar N, Grill V, Kaprio J (2003). "Alcohol consumption and the incidence of type 2 diabetes: a 20-year follow-up of the Finnish twin cohort study". Diabetes Care. 26 (10): 2785–2790. doi: 10.2337/diacare.26.10.2785 . PMID   14514580.
  188. Star VL, Hochberg MC (February 1993). "Prevention and management of gout". Drugs. 45 (2): 212–22. doi:10.2165/00003495-199345020-00004. PMID   7681372. S2CID   36034581.
  189. Eggebeen AT (September 2007). "Gout: an update". Am Fam Physician. 76 (6): 801–8. PMID   17910294.
  190. "Rheumatoid Arthritis". Archived from the original on 2008-06-13. Retrieved 2008-06-18.
  191. Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Hakala M (January 2000). "Reduced incidence of alcohol related deaths in subjects with rheumatoid arthritis". Ann. Rheum. Dis. 59 (1): 75–6. doi:10.1136/ard.59.1.75. PMC   1752983 . PMID   10627433.
  192. Nagata C, Fujita S, Iwata H, et al. (May 1995). "Systemic lupus erythematosus: a case-control epidemiologic study in Japan". Int J Dermatol. 34 (5): 333–7. doi:10.1111/j.1365-4362.1995.tb03614.x. PMID   7607794. S2CID   24940881.
  193. Aho K, Heliövaara M (December 1993). "Alcohol, androgens and arthritis". Ann. Rheum. Dis. 52 (12): 897. doi:10.1136/ard.52.12.897-b. PMC   1005228 . PMID   8311545.
  194. Hardy CJ, Palmer BP, Muir KR, Sutton AJ, Powell RJ (August 1998). "Smoking history, alcohol consumption, and systemic lupus erythematosus: a case-control study". Ann. Rheum. Dis. 57 (8): 451–5. doi:10.1136/ard.57.8.451. PMC   1752721 . PMID   9797548.
  195. Källberg H, Jacobsen S, Bengtsson C, et al. (July 2008). "Alcohol consumption is associated with decreased risk of rheumatoid arthritis; Results from two Scandinavian case-control studies". Ann. Rheum. Dis. 68 (2): 222–7. doi:10.1136/ard.2007.086314. PMC   2937278 . PMID   18535114.
  196. Jonsson IM, Verdrengh M, Brisslert M, et al. (January 2007). "Ethanol prevents development of destructive arthritis". Proc Natl Acad Sci USA. 104 (1): 258–63. doi: 10.1073/pnas.0608620104 . PMC   1765445 . PMID   17185416.
  197. Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Hakala M (January 2000). "Reduced incidence of alcohol related deaths in subjects with rheumatoid arthritis". Ann. Rheum. Dis. 59 (1): 75–6. doi:10.1136/ard.59.1.75. PMC   1752983 . PMID   10627433.
  198. Voigt LF, Koepsell TD, Nelson JL, Dugowson CE, Daling JR (September 1994). "Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis". Epidemiology. 5 (5): 525–32. PMID   7986867.
  199. Siris ES, Miller PD, Barrett-Connor E, et al. (December 2001). "Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment". JAMA. 286 (22): 2815–22. doi:10.1001/jama.286.22.2815. PMID   11735756.
  200. Rapuri PB, Gallagher JC, Balhorn KE, Ryschon KL (1 November 2000). "Alcohol intake and bone metabolism in elderly women". Am. J. Clin. Nutr. 72 (5): 1206–13. doi: 10.1093/ajcn/72.5.1206 . PMID   11063451. Archived from the original on 27 May 2012.
  201. Holbrook TL, Barrett-Connor E (June 1993). "A prospective study of alcohol consumption and bone mineral density". BMJ. 306 (6891): 1506–9. doi:10.1136/bmj.306.6891.1506. PMC   1677960 . PMID   8518677.
  202. 1 2 Ronis, MJ.; Wands, JR.; Badger, TM.; de la Monte, SM.; Lang, CH.; Calissendorff, J. (Aug 2007). "Alcohol-induced disruption of endocrine signaling". Alcohol Clin Exp Res. 31 (8): 1269–85. doi:10.1111/j.1530-0277.2007.00436.x. PMID   17559547.
  203. Peer, KS.; Newsham, KR. (2005). "A case study on osteoporosis in a male athlete: looking beyond the usual suspects". Orthop Nurs. 24 (3): 193–9, quiz 200–1. doi:10.1097/00006416-200505000-00007. PMID   15928528. S2CID   23377405.
  204. Kostović K, Lipozencić J (2004). "Skin diseases in alcoholics". Acta Dermatovenerol Croat. 12 (3): 181–90. PMID   15369644.
  205. Qureshi Abrar A.; Dominguez Patrick L.; Choi Hyon K.; Han Jiali; Curhan Gary (2010). "Alcohol Intake and Risk of Incident Psoriasis in US Women: A Prospective Study". Arch Dermatol. 146 (12): 1364–1369. doi:10.1001/archdermatol.2010.204. PMC   3017376 . PMID   20713772.
  206. Cohen S, Tyrrell DA, Russell MA, Jarvis MJ, Smith AP (September 1993). "Smoking, alcohol consumption, and susceptibility to the common cold". Am J Public Health. 83 (9): 1277–83. doi:10.2105/AJPH.83.9.1277. PMC   1694990 . PMID   8363004.
  207. Takkouche B, Regueira-Méndez C, García-Closas R, Figueiras A, Gestal-Otero JJ, Hernán MA (May 2002). "Intake of wine, beer, and spirits and the risk of clinical common cold". Am J Epidemiol. 155 (9): 853–8. doi: 10.1093/aje/155.9.853 . PMID   11978590.
  208. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Volume 44 Alcohol Drinking: Summary of Data Reported and Evaluation Archived 2012-06-17 at the Wayback Machine
  209. National Toxicology Program Alcoholic Beverage Consumption: Known to be a human carcinogen Archived 2010-06-05 at the Wayback Machine First listed in the Ninth Report on Carcinogens (2000)(PDF)
  210. Boffetta P, Hashibe M, La Vecchia C, Zatonski W, Rehm J (August 2006). "The burden of cancer attributable to alcohol drinking". International Journal of Cancer. 119 (4): 884–7. doi:10.1002/ijc.21903. hdl: 2434/22728 . PMID   16557583. S2CID   14938863.
  211. BBC News Drinking over recommended limit 'raises cancer risk' 8 April 2011
  212. Schütze Madlen; et al. (2011). "Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study". BMJ. 342: d1584. doi:10.1136/bmj.d1584. PMC   3072472 . PMID   21474525.
  213. WCRF World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: AICR, 2007 Archived 2013-05-23 at the Wayback Machine
  214. LoConte NK, Brewster AM, Kaur JS, Merrill JK, Alberg AJ (2018). "Alcohol and Cancer: A Statement of the American Society of Clinical Oncology". J. Clin. Oncol. 36 (1): 83–93. doi:10.1200/JCO.2017.76.1155. PMID   29112463. S2CID   25271140. Clearly, the greatest cancer risks are concentrated in the heavy and moderate drinker categories. Nevertheless, some cancer risk persists even at low levels of consumption. A meta-analysis that focused solely on cancer risks associated with drinking one drink or fewer per day observed that this level of alcohol consumption was still associated with some elevated risk for squamous cell carcinoma of the esophagus (sRR, 1.30; 95% CI, 1.09 to 1.56), oropharyngeal cancer (sRR, 1.17; 95% CI, 1.06 to 1.29), and breast cancer (sRR, 1.05; 95% CI, 1.02 to 1.08), but no discernable associations were seen for cancers of the colorectum, larynx, and liver.
  215. Garaycoechea, Juan I.; Crossan, Gerry P.; Langevin, Frédéric; Mulderrig, Lee; Louzada, Sandra; Yang, Fentang; Guilbaud, Guillaume; Park, Naomi; Roerink, Sophie (2018-01-03). "Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells". Nature. 553 (7687): 171–177. Bibcode:2018Natur.553..171G. doi:10.1038/nature25154. ISSN   1476-4687. PMC   6047743 . PMID   29323295.
  216. Homann N, Stickel F, König IR, et al. (2006). "Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkers". International Journal of Cancer. 118 (8): 1998–2002. doi: 10.1002/ijc.21583 . PMID   16287084. S2CID   11716548.
  217. Seitz HK, Stickel F (Aug 2007). "Molecular mechanisms of alcohol-mediated carcinogenesis" (PDF). Nat Rev Cancer. 7 (8): 599–612. doi:10.1038/nrc2191. PMID   17646865. S2CID   3231314. Archived from the original (PDF) on 2017-08-10. Retrieved 2013-01-19.
  218. Brooks P, Theruvathu J (2006). "Acetaldehyde-DNA Adducts: Implications for the Molecular Mechanism of Alcohol-Related Carcinogenesis". In Cho CH, Purohit V (eds.). Alcohol, Tobacco and Cancer. Vol. 2006. Basel: Karger. pp. 78–94. ISBN   978-3-8055-8107-3.
  219. Andréasson, S; Allebeck, P (2005). "Alcohol as medication is no good. More risks than benefits according to a survey of current knowledge". Läkartidningen. 102 (9): 632–7. PMID   15804034.
  220. Ulleland CN (May 1972). "The offspring of alcoholic mothers". Annals of the New York Academy of Sciences. 197 (1): 167–9. Bibcode:1972NYASA.197..167U. doi:10.1111/j.1749-6632.1972.tb28142.x. PMID   4504588. S2CID   84514766.
  221. Abel EL, Sokol RJ (January 1987). "Incidence of foetal alcohol syndrome and economic impact of FAS-related anomalies". Drug Alcohol Depend. 19 (1): 51–70. doi:10.1016/0376-8716(87)90087-1. PMID   3545731.
  222. 1 2 3 4 5 6 Kearns-Bodkin, Jill N.; Leonard, Kenneth E. (November 2008). "Relationship Functioning Among Adult Children of Alcoholics". Journal of Studies on Alcohol and Drugs. 69 (6): 941–950. doi:10.15288/jsad.2008.69.941. PMC   2583382 . PMID   18925353.
  223. 1 2 Finger, Brent; Kachadourian, Lorig K.; Molnar, Danielle S.; Eiden, Rina D.; Edwards, Ellen P.; Leonard, Kenneth E. (June 2010). "Alcoholism, associated risk factors, and harsh parenting among fathers: Examining the role of marital aggression". Addictive Behaviors. 35 (6): 541–548. doi:10.1016/j.addbeh.2009.12.029. PMC   3824378 . PMID   20153586.
  224. 1 2 3 Sher, K (1991). "Characteristics of Children of Alcoholics: Putative Risk Factors, Substance Use and Abuse, and Psychopathology". Journal of Abnormal Psychology. 100 (4): 427–448. doi:10.1037/0021-843x.100.4.427. PMID   1757657.
  225. 1 2 3 4 Gerhant, A. (2016). "Personality Traits in Alcohol-Dependent Individuals in the Context of Childhood Abuse". Psychiatria Polska. 50 (5): 973–987. doi: 10.12740/pp/60346 . PMID   27992890.
  226. 1 2 3 4 5 Adkison, Sarah E.; Grohman, Kerry; Colder, Craig R.; Leonard, Kenneth; Orrange-Torchia, Toni; Peterson, Ellen; Eiden, Rina D. (2013). "Impact of Fathers' Alcohol Problems on the Development of Effortful Control in Early Adolescence". Journal of Studies on Alcohol and Drugs. 74 (5): 674–683. doi:10.15288/jsad.2013.74.674. PMC   3749310 . PMID   23948526.
  227. 1 2 Verhaeghe, Nick; Lievens, Delfine; Annemans, Lieven; Vander Laenen, Freya; Putman, Koen (2017-01-18). "Methodological Considerations in Social Cost Studies of Addictive Substances: A Systematic Literature Review". Frontiers in Public Health. 4: 295. doi: 10.3389/fpubh.2016.00295 . ISSN   2296-2565. PMC   5241275 . PMID   28149834.
  228. Rice, Dorothy P. (2000-09-01). "Cost of illness studies: what is good about them?". Injury Prevention. 6 (3): 177–179. doi:10.1136/ip.6.3.177. ISSN   1353-8047. PMC   1730654 . PMID   11003181.
  229. Manthey, Jakob; Laramée, Philippe; Parrott, Steve; Rehm, Jürgen (2016-08-31). "Economic burden associated with alcohol dependence in a German primary care sample: a bottom-up study". BMC Public Health. 16 (1): 906. doi: 10.1186/s12889-016-3578-8 . ISSN   1471-2458. PMC   5006576 . PMID   27576562.
  230. Odlaug, B.L.; Gual, A.; DeCourcy, J.; Perry, R.; Pike, J.; Heron, L.; Rehm, J. (2016-03-01). "Alcohol Dependence, Co-occurring Conditions and Attributable Burden". Alcohol and Alcoholism. 51 (2): 201–209. doi:10.1093/alcalc/agv088. ISSN   0735-0414. PMC   4755551 . PMID   26246514.
  231. Rehm, Jürgen (2011). "The Risks Associated With Alcohol Use and Alcoholism". Alcohol Research & Health. 34 (2): 135–143. ISSN   1535-7414. PMC   3307043 . PMID   22330211.
  232. Bouchery, Ellen E.; Harwood, Henrick J.; Sacks, Jeffrey J.; Simon, Carol J.; Brewer, Robert D. (2011-11-01). "Economic Costs of Excessive Alcohol Consumption in the U.S., 2006". American Journal of Preventive Medicine. 41 (5): 516–524. CiteSeerX   10.1.1.460.5582 . doi:10.1016/j.amepre.2011.06.045. ISSN   0749-3797. PMID   22011424.
  233. Rehm, Jürgen; Mathers, Colin; Popova, Svetlana; Thavorncharoensap, Montarat; Teerawattananon, Yot; Patra, Jayadeep (2009-06-27). "Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders". Lancet. 373 (9682): 2223–2233. doi:10.1016/S0140-6736(09)60746-7. ISSN   1474-547X. PMID   19560604. S2CID   27947246.
  234. Thavorncharoensap, Montarat; Teerawattananon, Yot; Yothasamut, Jomkwan; Lertpitakpong, Chanida; Thitiboonsuwan, Khannika; Neramitpitagkul, Prapag; Chaikledkaew, Usa (2010-06-09). "The economic costs of alcohol consumption in Thailand, 2006". BMC Public Health. 10: 323. doi: 10.1186/1471-2458-10-323 . ISSN   1471-2458. PMC   2896941 . PMID   20534112.
  235. Thavorncharoensap, Montarat; Teerawattananon, Yot; Yothasamut, Jomkwan; Lertpitakpong, Chanida; Chaikledkaew, Usa (2009-11-25). "The economic impact of alcohol consumption: a systematic review". Substance Abuse Treatment, Prevention, and Policy. 4: 20. doi: 10.1186/1747-597X-4-20 . ISSN   1747-597X. PMC   2791094 . PMID   19939238.
  236. Jarl, Johan; Johansson, Pia; Eriksson, Antonina; Eriksson, Mimmi; Gerdtham, Ulf-G.; Hemström, Orjan; Selin, Klara Hradilova; Lenke, Leif; Ramstedt, Mats (November 2008). "The societal cost of alcohol consumption: an estimation of the economic and human cost including health effects in Sweden, 2002". The European Journal of Health Economics. 9 (4): 351–360. doi:10.1007/s10198-007-0082-1. ISSN   1618-7598. PMID   18043953. S2CID   20912577.
  237. "The Social Costs of Drug Abuse in Australia in 1988 and 1992 (PDF Download Available)". ResearchGate. Retrieved 2017-09-17.